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ABSTRACT 
Type 2 diabetes is a major public health threat globally, associated with severe medical 
complications such as cardiovascular diseases and damage to kidneys, eyes, and nerves, as 
well as with premature death. Dietary factors are of importance in both primary prevention 
and disease management. Fish consumption is of interest given the observed benefits on 
several cardiometabolic risk factors. Such benefits have largely been attributed to the content 
of long-chain omega-3 fatty acids, but may also be related to a wider range of nutrients. On 
the negative side, there is also the potential of adverse effects by contaminants present in 
some types of fish.  
This thesis includes four papers in which we aimed to: 1) summarize results from prospective 
studies on the associations of fish consumption and intake of long-chain omega-3 fatty acids 
with risk of type 2 diabetes; 2) evaluate the validity of food frequency questionnaire (FFQ)-
based estimates of these exposures; 3) examine the associations of total and specific types of 
fish with risk of type 2 diabetes, taking environmental contaminants into account; and 4) 
examine the associations of total and specific types of fish with risk of myocardial infarction 
(MI), stroke, and mortality among people with diagnosed type 2 diabetes. 
Our meta-analysis showed that the accumulated observational evidence on fish consumption 
and long-chain omega-3 fatty acid intake in relation to type 2 diabetes risk is heterogeneous 
across regions, with an increased risk reported in studies conducted in the US, no association 
reported in European studies, and lower risk reported in Asian/Australian studies.  
The three latter papers are based on data from two large Swedish population-based cohorts of 
nearly 90,000 women and men, whose dietary habits were assessed via FFQs in 1997. We 
showed that the estimates of long-chain omega-3 fatty acid intake correlated with adipose 
tissue content of these fatty acids in a subsample of 239 women, supporting their validity. 
Participants were followed for the outcomes of interest through December 2012, by linkage 
to nationwide registers. In men, total fish consumption was not associated with type 2 
diabetes in the primary analysis. Taking dietary exposure to polychlorinated biphenyls 
(PCBs) and methylmercury (MeHg) into account, there was however a suggestion of an 
inverse association. High consumption of shellfish and fried fish was associated with higher 
risk of type 2 diabetes. Among women and men with type 2 diabetes before baseline, fish 
consumption was inversely associated with MI, while there was no support for an association 
with stroke. The results for total and coronary heart disease (CHD)-related mortality were 
inconclusive with some suggestion of lower risk associated with moderate fish consumption.  
Overall, the results presented in this thesis do not challenge the current recommendations on 
regular fish consumption. General advice may however be too imprecise, and more specific 
recommendations on fish species and preparation methods may be warranted.  
 POPULÄRVETENSKAPLIG SAMMANFATTNING 
I den här avhandlingen undersöks sambanden mellan fiskkonsumtion och uppkomst av typ 2-
diabetes samt några av de komplikationer som är kopplade till sjukdomen. 
Typ 2-diabetes är ett omfattande folkhälsoproblem över hela världen. Förekomsten har ökat 
kraftigt under de senaste decennierna, och ökningen förväntas fortsätta. Vid diabetes är 
blodsockerhalten förhöjd på grund av brist på hormonet insulin som behövs för att sockret 
ska tas upp i cellerna. Typ 2-diabetes är den vanligaste formen och debuterar oftast vid vuxen 
ålder. Vanligtvis kommer den smygande med otydliga tidiga symptom, vilket gör att det kan 
dröja flera år innan sjukdomen upptäcks. Vid typ 2-diabetes kan kroppen fortfarande tillverka 
insulin, men på grund av insulinresistens svarar cellerna inte som förväntat och insulinet 
räcker därför inte för att hålla blodsockret under kontroll. De höga sockernivåerna kan leda 
till skador på blodkärlen och därigenom till ett flertal följdsjukdomar. Påverkan på ögon, 
njurar och nerver kan i förlängningen ge allvarliga problem som synförsämringar, nedsatt 
känsel och fotsår, samt njursvikt. Personer med diabetes löper även en flerfalt förhöjd risk att 
utveckla hjärtkärlsjukdomar som hjärtinfarkt och stroke, som också är de främsta orsakerna 
till förhöjd dödlighet i den här gruppen.  
Sjukdomen beror delvis på ärftliga faktorer, men det är även väl belagt att levnadsvanor är av 
stor betydelse. Det finns en stark koppling till övervikt och fysisk inaktivitet, eftersom dessa 
faktorer bidrar till insulinresistens. På senare tid har mer och mer forskning undersökt 
betydelsen av specifika kostfaktorer, men mycket återstår att klarlägga. För de som redan 
insjuknat i diabetes är goda kostvanor av stor betydelse för att hålla blodsockernivåerna under 
kontroll och förebygga uppkomsten av komplikationer.  
Fisk är ett högintressant livsmedel, eftersom det har kopplats till fördelaktiga effekter på 
riskfaktorer som till exempel blodtryck och blodfetter. Man har också sett att de som äter 
mycket fisk löper lägre risk att insjukna i hjärtkärlsjukdom jämfört med de som äter lite fisk. 
Man tror att detta till stor del beror på fiskens innehåll av omega-3 fettsyror, men den lägre 
risken skulle även kunna kopplas till andra viktiga näringsämnen. Ett orosmoment är dock att 
vissa typer av fisk innehåller höga halter av miljöföroreningar som kan ha negativ inverkan. 
Tidigare studier som har undersökt sambandet mellan fiskkonsumtion och uppkomst av typ-2 
diabetes har visat tvetydiga resultat. Väldigt få studier har hittills genomförts för att 
undersöka fiskens betydelse för uppkomst av hjärtkärlsjukdomar bland personer med diabetes 
vid studiens start. Syftet med denna avhandling var därför att undersöka dessa samband 
vidare.  
De fyra ingående delarbetena syftade till att: 1) genom en metaanalys sammanfatta resultat 
från tidigare uppföljningsstudier på fiskkonsumtion och intag omega-3 fettsyror i relation till 
uppkomst av typ 2-diabetes; 2) utvärdera hur väl rapportering av fiskkonsumtion och intag av 
  
omega-3 fettsyror som gjorts med hjälp av kostenkäter stämmer överens med uppmätta 
nivåer av omega-3 fettsyror i fettvävnad; 3) undersöka sambandet mellan fiskkonsumtion och 
uppkomst av typ 2-diabetes, med hänsyn tagen även till miljögifter i fisk; och 4) undersöka 
sambandet mellan fiskkonsumtion och risk för hjärtinfarkt, stroke och dödlighet bland 
personer med typ 2-diabetes från studiens start. 
Vår metaanalys i det första delarbetet visade att resultaten från hittills publicerad forskning 
på fiskkonsumtion och intag av omega-3 fettsyror i förhållande till uppkomst av typ 2-
diabetes i stor utsträckning skiljer sig åt mellan olika delar av världen. Sammanfattningen av 
studier från USA tyder på förhöjd risk, medan europeiska studier inte sett något samband och 
studier från Asien och Australien tyder på lägre risk. Vad detta beror på återstår att studera, 
men skulle rimligtvis kunna kopplas till skillnader i konsumtionsmönster, tillagningsmetoder, 
vilken typ av fisk man äter och möjligtvis skillnader i fiskens innehåll av miljöföroreningar.  
För de senare tre delarbetena användes data från två stora svenska studier på kvinnor och män 
som rapporterade sina kostvanor via detaljerade enkäter under hösten 1997. I det andra 
delarbetet kunde vi påvisa att enkätsvaren på ett adekvat sätt speglar det faktiska intaget. 
Detta gjordes genom att jämföra det självrapporterade intaget av fisk och vår enkätbaserade 
beräkning av omega-3 fettsyreintag mot uppmätta nivåer av dessa fettsyror i fettvävnaden hos 
en mindre grupp av kvinnorna i studien.  
Via nationella register identifierade vi studiedeltagare som insjuknat i typ 2-diabetes, 
hjärtinfarkt eller stroke, samt de som avlidit fram till och med 31 december 2012. Genom 
statistiska modeller som tar hänsyn till andra kost- och levnadsvanor beräknades sedan hur 
risken för dessa utfall varierade med den rapporterade fiskkonsumtionen.  
Våra huvudresultat från det tredje delarbetet visade att fiskkonsumtion inte var kopplad till 
uppkomst av typ 2-diabetes. Vi kunde se en antydan till lägre risk efter att vi med statistiska 
verktyg bortsett från miljöföroreningar i fisken (PCB och kvicksilver). Detta är dock en 
teoretisk modell, och mer forskning är nödvändig för att utreda betydelsen av dessa 
föroreningar. Risken för typ 2-diabetes var högre bland de deltagare som rapporterade hög 
konsumtion av skaldjur och stekt fisk.  
I det fjärde delarbetet utgick vi från deltagare som hade typ 2-diabetes redan vid studiens 
start. Fiskkonsumtion var i denna grupp kopplad till lägre risk för hjärtinfarkt, medan vi inte 
fann något stöd för en koppling till stroke. Resultaten för dödlighet var inte tillräckligt tydliga 
för att dra några säkra slutsatser, men antydde fördelar förknippade med måttlig konsumtion 
av fisk.  
Sammanfattningsvis stödjer resultaten från denna avhandling de befintliga kostråden om 
regelbunden fiskkonsumtion. Mer specifika rekommendationer om olika fiskarter, ursprung 
och tillagningsmetoder kan dock vara motiverade.  
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 1 INTRODUCTION 
This thesis focuses on the associations of fish consumption with risk of incident type 2 
diabetes and some of its cardiovascular complications, including myocardial infarction (MI) 
and stroke, as well as mortality.  
Type 2 diabetes is one of the world‟s major public health problems, with a prevalence that 
has been rapidly increasing over the past decades and is expected to continue to do so in the 
coming years.
1
 It is a severe disease associated with serious medical complications and 
premature death. The excess blood glucose that characterizes diabetes can directly or 
indirectly cause damage to the cardiovascular system, kidneys, nerves, and eyes, and thus 
impose a great personal burden for affected individuals as well as a substantial economic 
burden on health care systems.  
Lifestyle factors, including diet, are key components in primary prevention as well as in 
disease management and prevention of complications. However, gaps in the scientific 
evidence for dietary recommendations of specific foods still remain. The role of fish 
consumption in development and progression of type 2 diabetes is an area in need of 
clarification. Although fish has been associated with beneficial effects on risk factors 
associated with diabetes,
2
 as well as on cardiovascular disease development in the general 
population,
3-5
 studies on type 2 diabetes incidence have provided largely heterogonous 
results,
6-19
 and studies on cardiovascular disease outcomes specifically in populations with 
diabetes are scarce.
20-22
 
Fish is generally a highly nutritious food, containing a number of important nutrients that 
may be hard to obtain in sufficient amounts from other food sources. Various fish species 
however differ in nutritional composition, and factors such as preparation method may further 
influence the benefits of consumption. Fish is also a major source of dietary exposure to some 
environmental contaminants, such as polychlorinated biphenyls (PCBs) and methylmercury 
(MeHg). Thus, consideration of several aspects is of importance to enhance the understanding 
of the role of fish consumption and eventually allow for development of more specific dietary 
recommendations.  
 2 BACKGROUND 
2.1 TYPE 2 DIABETES 
Diabetes mellitus is a group of metabolic diseases, all characterized by hyperglycemia 
resulting from insulin deficiency. Type 2 diabetes is the most common form, accounting for 
about 90% of all diabetes, and a major public health problem throughout the world.
1
 To 
distinguish it from type 1 diabetes, which is often diagnosed in childhood, type 2 diabetes has 
commonly been referred to as adult-onset diabetes. However, with growing prevalence it is 
increasingly seen in younger age groups.
23
 Another historical name aiming to distinguish it 
from type 1 diabetes, which is invariably treated with insulin, was non-insulin dependent 
diabetes. However, although it is often initially managed without insulin treatment, many 
type 2 diabetes patients come to rely on insulin therapy as the disease progresses.
24
 The 
difference between type 1 and type 2 diabetes lies in the underlying pathophysiological 
defects. Whereas type 1 diabetes is an autoimmune disease that causes destruction of insulin 
producing cells, the insulin deficiency in type 2 diabetes is relative and progresses as the body 
can no longer compensate for an increased insulin demand.
25
  
2.1.1 Descriptive epidemiology 
According to prevalence estimates from the International Diabetes Federation (IDF) for 2015, 
415 million people worldwide (8.8% of the adult population) are living with diabetes. This 
estimate includes 193 million undiagnosed.
1
 The prevalence has been increasing continuously 
over the past decades, and is predicted to rise to 642 million by 2040.
1
  
In large parts of the world, the prevalence has increased dramatically alongside an economic 
development that has driven rapid changes in age distribution as well as in lifestyle 
behaviors.
1
 The highest age-adjusted percentage prevalence is presently found in the North 
America and Caribbean Region (Figure 2.1). The largest absolute number is found in the 
highly populous Western Pacific Region (153 million people).
1
   
In Sweden, diabetes prevalence among adults was estimated to 4.2% based on self-reports 
from the latest Living Conditions Surveys (ULF/SILC) in 2012–2013.26 The IDF estimation, 
including undiagnosed cases, is a total prevalence of 6.3% of adults.
1
 An increase in 
prevalence has been seen over the past decades, although less drastic than in many other parts 
of the world.
27-29
 The incidence however appears to have leveled off, and the rise in 
prevalence is mainly ascribed to changes in the age distribution and to improved survival 
among people with diabetes.
27-29
 Given the increase in overweight and obesity in Sweden 
over the past decades, not the least in children and young adults, it is possible that an increase 
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in diabetes incidence is yet to manifest itself.
30
 However, also with a stable incidence, or even 
some decline, changes in age structure and survival will result in a continued rise in 
prevalence, with a major impact on public health.
27
 
 
 
 
Figure 2.1  Age-adjusted prevalence of diabetes among adults (20–79 years), by International Diabetes 
Federation region. AFR, Africa; EUR, Europe; MENA, Middle East and North Africa; NAC, North America and 
Caribbean; SCA, South and Central America; SEA, South East Asia; WP, Western Pacific. Data source: 
International Diabetes Federation
1
 
2.1.2 Pathophysiology 
The two core pathophysiological features in type 2 diabetes are insulin resistance and 
pancreatic β-cell dysfunction. Blood glucose levels deteriorate only if insulin resistance is 
accompanied by an impaired capacity to enhance insulin secretion.
31
 The onset of the disease 
is gradual and impairment of insulin action and β-cell function have generally progressed 
over several years before type 2 diabetes can be diagnosed.
32
 
The manifestations of inadequate insulin response in the main insulin-sensitive tissues – 
skeletal muscle, liver, and adipose tissue – contribute to hyperglycemia in different ways. 
Uptake in skeletal muscle is a key mechanism for postprandial glucose disposal, and impaired 
insulin-mediated transport into the cells contributes to increasing blood levels.
31
 In the liver, 
glucose production is increased due to impaired insulin-induced suppression.
31
 In adipocytes, 
insulin-mediated regulation of lipolysis is disturbed, leading to elevated levels of circulating 
free fatty acids.
33
 Chronic exposure to excess free fatty acids aggravates hyperglycemia by 
stimulating hepatic gluconeogenesis, inducing insulin resistance and impairing insulin 
secretion; a phenomenon referred to as lipotoxicity.
31, 33
 Moreover, hyperglycemia itself 
accelerates the disease progression by impairing both insulin action and insulin secretion; a 
vicious cycle known as glucotoxicity.
31
  
AFR 3.8% 
EUR 7.3% 
WP 8.8% 
SCA 9.6% 
MENA 10.7% 
SEA 8.8% 
NAC 11.5% 
2   Background 
 
 
 5 
2.1.3 Diagnosis and definitions 
The World Health Organization (WHO) diagnostic criteria for diabetes are fasting plasma 
glucose ≥7.0 mmol/L and/or plasma glucose ≥11.1 mmol/L two hours after an oral glucose 
load of 75 grams.
34
 Measurement of glycated hemoglobin (HbA1c), which reflects average 
blood glucose levels over the previous 8–12 weeks, is an alternative diagnostic test. This 
method may be more practical as is does not require a fasting sample. An HbA1c of 48 
mmol/mol (6.5%) is the recommended cut point for diagnosis.
35
  
Diabetes type is assigned largely based on the circumstances at the time of diagnosis, and not 
all patients are easily classified.
36
 The majority of diabetes cases fall into the two broad 
categories of type 1 or type 2. There are also other types, such as gestational diabetes, 
monogenic forms, and secondary diabetes due to pancreatic damage.
36
 A type that is often 
misinterpreted as type 2, but shares the autoimmune characteristics of type 1, is latent 
autoimmune diabetes in adults (LADA).
37
  
Because of the slow onset and non-specific initial symptoms, type 2 diabetes often remains 
undiagnosed for several years.
25
 It is not uncommon that severe complications have emerged 
already before diagnosis.
1
 The proportion of undiagnosed is largest in low- and middle-
income countries. In Sweden it is estimated that about 38% of all adults with diabetes are 
unaware of their disease.
1
  
2.1.3.1 Prediabetes 
The hyperglycemia in type 2 diabetes develops progressively via a stage commonly referred 
to as prediabetes. The definition of prediabetes includes impaired fasting glucose (IFG; 
fasting plasma glucose of 6.1–6.9 mmol/L34 or 5.6–6.9 mmol/L25) and impaired glucose 
tolerance (IGT; two-hour postload plasma glucose of 7.8–11.0 mmol/L34). People with 
prediabetes are at high risk of developing type 2 diabetes, but lifestyle or pharmacological 
interventions in this high-risk group have been shown to be effective to prevent progression.
38
 
2.1.3.2 Metabolic syndrome  
Prediabetes commonly clusters with other cardiometabolic risk factors which together are 
referred to as the metabolic syndrome. Several definitions of the metabolic syndrome exist, 
including some combination of elevated fasting glucose or glucose intolerance, abdominal 
obesity, high triglyceride levels, low high density lipoprotein (HDL) cholesterol, and 
hypertension.
39
 This concept identifies a patient group at high risk of both type 2 diabetes and 
cardiovascular disease.  
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2.1.4 Complications  
Type 2 diabetes is associated with a number of medical complications due to damages caused 
by long-term elevated blood glucose and related metabolic disturbances. These affect the 
heart and blood vessels, eyes, kidneys, and nerves, and are typically classified into 
microvascular and macrovascular complications.
40
 
2.1.4.1 Microvascular complications 
Microvascular complications refer to damage to the small blood vessels, and include 
complications in the eyes, nerves, and kidneys. In most high-income countries, diabetes is a 
leading cause of blindness, lower-limb amputations, and kidney failure.
1
 Development and 
severity of these complications is strongly associated with the magnitude and duration of 
hyperglycemia.
40
  
Damage to the retina of the eye affects most individuals with diabetes to some extent, and 
often begin to develop long before the diabetes diagnosis.
40
 If severe, it can cause visual 
impairment and even blindness, but it can become quite advanced before the vision is 
affected.
1
 Nerve damage most commonly affects peripheral nerves. Sensation loss can cause 
injuries to go unnoticed and contribute to foot problems for many patients. Poor circulation 
and elevated susceptibility to infection may further contribute to ulceration, which in serious 
cases requires amputation.
1
 Nerve damage can occur also in other organ systems and cause 
problems such as erectile dysfunction, bladder dysfunction, and problems with digestion.
40
 
Signs of kidney dysfunction at the level of microalbuminuria are common among type 2 
diabetes patients. Without proper intervention it may progress to more severe kidney disease 
and kidney failure.
40
  
2.1.4.2 Macrovascular complications  
Macrovascular complications refer to complications of the larger blood vessels, contributing 
to atherosclerosis and increased risk of angina, myocardial infarction (MI), stroke, congestive 
heart failure, and peripheral artery disease.
1
 The risk of developing cardiovascular disease is 
several times higher in people with type 2 diabetes compared to the general population, with 
a greater risk increase in women than in men.
41
 This group of diseases constitute the primary 
cause of death among people with diabetes, as well as the main component of diabetes-
related health care expenditures.
40
  
Type 2 diabetes is commonly accompanied by a cluster of traditional cardiovascular risk 
factors, such as elevated low density lipoprotein (LDL) cholesterol levels, low HDL 
cholesterol levels, and high blood pressure. The cardiovascular risk among people with 
diabetes can however not be explained by these factors alone, but is further added to by the 
effects of hyperglycemia and insulin resistance. These effects include aggravated 
dyslipidemia and hypertension, overproduction of reactive oxygen species, low-grade 
inflammation, impaired endothelial function, and thrombotic abnormalities.
41
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2.1.5 Management 
The main treatment goal in type 2 diabetes is to control blood glucose levels in order to 
prevent and manage its complications. Management of coexisting conditions such as 
hypertension and dyslipidemia is also of major importance.
42, 43
 Most patients are initially 
treated with oral blood glucose-lowering drugs in combination with counseling on healthy 
diet and physical activity. As the disease progresses, many patients come to depend on insulin 
treatment.
24, 42
   
Recommendations for dietary management of diabetes from the American Diabetes 
Association,
44
 as well as guidelines from the Swedish National Board of Health and 
Welfare,
45
 recognize that a main focus for many patients is to control overall energy intake. 
Emphasis is put on individualization and flexibility to allow long-term adherence to the 
dietary plan. Monitoring carbohydrate intake is central for glycemic control, but there is no 
support for very low carbohydrate diets. Instead, the focus should be on quality rather than 
quantity. A 2013 meta-analysis of twenty randomized controlled trials of dietary 
interventions in type 2 diabetes concluded that a variety of diets, such as low-carbohydrate, 
low glycemic index, Mediterranean, and high-protein diets, may be effective for improving 
glycemic control, lipid profile, and body weight.
46
 Evidence from studies on dietary factors in 
relation to major cardiovascular events and mortality in people with diabetes is more sparse, 
and recommendations on specific foods and nutrients are to some extent based on what is 
known about healthy eating habits for the general population.
44, 45, 47
  
2.1.6 Risk factors 
Although the causes of type 2 diabetes are not completely understood, several risk factors of 
importance have been identified. Both genetic susceptibility and triggering environmental 
risk factors, as well as interactions between the two, contribute to disease development.
48
  
2.1.6.1 Non-modifiable factors  
Family history has long been recognized as an important risk factor, with first-degree 
relatives being at two- to sixfold higher risk of developing type 2 diabetes.
49
 Twin studies 
have further supported a strong genetic link, with an estimated heritability of 40–80%.50 More 
recently, the advancements of genome-wide association methodology have rapidly increased 
the number of identified genetic variants associated with type 2 diabetes. To date, about 80 
loci have been linked to type 2 diabetes risk, but their individual effects are modest.
50
 
Although the biological functions are to a large extent unknown, most of these genetic 
variants seem to be related to β-cell function rather than insulin action.48     
Besides genetic susceptibility, important non-modifiable risk factors include increasing age, 
history of gestational diabetes, and polycystic ovarian syndrome.
51
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2.1.6.2 Modifiable factors 
Among the modifiable factors related to type 2 diabetes risk, obesity is singled out as the 
most important.
51
 Excess body fat, in particular centrally accumulated, is strongly associated 
with insulin resistance, and most people diagnosed with type 2 diabetes are overweight or 
obese.
52
 Physical inactivity is also a key risk factor, even independently of its effects on body 
composition.
51
 Exercise acutely activates non-insulin dependent glucose uptake in skeletal 
muscle, and regular physical activity leads to adaptations that improve long-term insulin 
sensitivity.
53
 Other lifestyle-related risk factors of importance include unhealthy dietary 
habits, smoking, and alcohol consumption.
51
 Factors such as psychological distress and work 
stress are also associated with higher risk.
54, 55
 
As previously noted, prediabetes and the metabolic syndrome are major risk factors for type 2 
diabetes development. These conditions are themselves largely influenced by the same 
modifiable risk factors.
51
 Several trials have demonstrated that progression to type 2 diabetes 
among people with prediabetes can be efficiently prevented with lifestyle interventions 
focusing on diet and physical activity.
56, 57
 
Specific dietary factors  
Over the past decades, evidence on associations between specific foods and dietary factors in 
relation to risk of type 2 diabetes has accumulated, in particular from prospective cohort 
studies. With the rapid accumulation of evidence, meta-analysis has become an important 
tool to summarize results from different studies. Prospective studies on type 2 diabetes risk 
have been summarized in recent meta-analyses for most major food groups (Figure 2.2).  
Red meat is among the foods that have been most consistently associated with higher risk of 
type 2 diabetes. In a meta-analysis from 2011, including nine cohort studies on unprocessed 
red meat and eight on processed red meat consumption, direct associations were observed for 
both types.
58
 Several studies have been published since, of which some have been in line with 
this conclusion,
59-61
 whereas others have observed direct associations only for processed red 
meat.
19, 62, 63
 A possible explanation behind the association relates to the heme iron content of 
red meat. Iron is a strong prooxidant, and both heme iron intake and high body iron stores 
have been associated with higher risk of type 2 diabetes.
64, 65
 Higher sodium content or 
preservatives such as nitrites and nitrates have been proposed to explain the stronger 
association with processed meat.
66, 67
  
Whole grain consumption was strongly associated with lower type 2 diabetes risk in a meta-
analysis from 2013.
68
 In the same study, no association was observed for total refined grain 
consumption, whereas specifically white rice was associated with higher risk. A separate 
meta-analysis on white rice consumption concluded that there was a stronger direct 
association in Asian populations where white rice is a major calorie source.
69
 Benefits of 
whole grain foods relates to the high fiber content and low glycemic index, which contributes 
to a more controlled elevation of postprandial blood glucose. On the contrary, refined grains 
have a high glycemic index, and a generally reduced nutrient content. 
Figure 2.2  Overview of summary relative risks (with horizontal lines representing 95% confidence intervals) from the most recently published meta-analyses of 
prospective studies on foods/food groups and beverages in relation to type 2 diabetes risk (n: number of studies included in meta-analysis; year of publication)  
a  
nonlinear association; relative risk shown for the consumption level most strongly associated with type 2 diabetes risk 
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A meta-analysis of prospective cohort studies of fruit and vegetable consumption from 
2015 reported nonlinear associations. Compared with consumption less than daily, the 
lowest type 2 diabetes risks were observed for three servings per day of vegetables and two 
servings per day of fruit, whereas no statistically significant associations were observed for 
higher consumption levels.
70
 The benefits of fruit and vegetable consumption may further 
differ by subtypes. Higher consumption of berries, green leafy vegetables, yellow 
vegetables, and cruciferous vegetables was associated with lower type 2 diabetes risk in 
another recent meta-analysis.
71
 Fruit and vegetables are rich in dietary fiber and a wide 
range of compounds with antioxidative properties which could explain the inverse 
associations.
71
   
Among dairy foods, only yogurt was associated with lower type 2 diabetes risk in a meta-
analysis from 2014.
72
 This could possibly be explained by the content of probiotic bacteria, 
which have been shown to have beneficial effects on lipid profile and antioxidant status.
73, 74
  
The inverse association with yogurt was supported in the only subsequently published cohort 
study.
75
  
The role of egg consumption has been debated, with several studies in US populations 
suggesting a direct association with type 2 diabetes. As concluded in recently published meta-
analysis, this association has not been supported in studies conducted in other regions, and 
the discrepancies could potentially be explained by differences in egg consumption habits and 
associated overall dietary patterns.
76
 
Nuts have been suggested to have beneficial effects because of their unsaturated fat content, 
and higher consumption was associated with lower type 2 diabetes risk in a meta-analysis 
from 2014.
77
 In addition to five cohort studies, this meta-analysis also included the 
PREDIMED (Prevención con Dieta Mediterránea) trial, in which supplementation of nuts 
significantly reduced incident diabetes in the context of a Mediterranean diet.
78
 
Among beverages, coffee consumption has been extensively studied in relation to type 2 
diabetes, and has been consistently associated with a lower risk.
79-82
 The inverse association 
has been observed for both caffeinated and decaffeinated coffee, indicating that other 
bioactive compounds may be of importance. Although a wide range of potential mediators 
have been investigated, the association has only been partly explained.
83
  
The association with tea consumption is less established, and results from prospective cohort 
studies have been largely inconsistent. A meta-analysis from 2014 found no significant 
relationship with type 2 diabetes overall, but an inverse association in studies evaluating 
consumption as high as three cups or more per day.
84
  
Sweetened beverage consumption has been associated with a higher risk of type 2 diabetes. 
In a meta-analysis published in 2015, a direct association was reported for sugar-sweetened 
beverage consumption, independently of adiposity.
85
 Direct associations were observed also 
for artificially sweetened beverages as well as for fruit juices, although these were less 
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consistently supported in sensitivity analyses. The only subsequent cohort study on these 
associations was consistent with the conclusion on sugar-sweetened beverages, whereas no 
association was observed for fruit juices, and a positive association with artificially 
sweetened beverages was attenuated after adjustment for adiposity.
86
 The proposed 
mechanisms of a positive association mainly relate to the sugar content, but there may also be 
effects of food colorings, phosphoric acid, or other constituents.
87
  
Moderate alcohol consumption has been suggested to confer benefits with regard to type 2 
diabetes development. The proposed mechanisms relate to increases in insulin sensitivity, 
increases in HDL cholesterol levels, or alterations of inflammatory proteins.
88
 The most 
recent meta-analysis on this topic was published earlier in 2016, and included 26 prospective 
observational studies. Light and moderate alcohol consumption was associated with lower 
risk of type 2 diabetes, whereas no association was observed for heavy consumption. The 
lower risk was observed at less than 20 grams per day for women and less than 40 grams per 
day for men.
89
 
The results on fish consumption in relation to type 2 diabetes risk have been largely 
inconsistent between published prospective studies,
90-96
 and are discussed more in detail in 
section 2.2 and 5.1.    
Dietary scores and patterns 
Adherence to diet quality scores such as the Dietary Approaches to Stop Hypertension 
(DASH) diet, the Alternate Healthy Eating Index (AHEI), the Mediterranean diet, and the 
Healthy Nordic Food Index, has also been associated with lower risk of type 2 diabetes.
97-99
 
In these scores a number of pre-specified „healthy‟ and „unhealthy‟ dietary factors are 
combined to obtain an overall estimate of diet quality. Another approach to assess overall diet 
is a posteriori defined dietary patterns, for which statistical methods are used to cluster 
dietary factors based on the data at hand. A recent meta-analysis of prospective studies using 
such approaches showed that adherence to „healthy‟ dietary patterns (generally defined by 
higher consumption of vegetables, fruits, whole grains, low-fat dairy, fish, poultry, and 
legumes) was associated with lower type 2 diabetes risk, while adherence to „unhealthy‟ 
patterns (generally defined by higher consumption of red meat, fried and processed foods, 
refined grains, sweets and desserts) was associated with higher type 2 diabetes risk.
100
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2.2 FISH CONSUMPTION 
Low rates of cardiometabolic diseases in Greenlandic Inuit populations with high fatty fish 
consumption sparked an interest in the health effects of fish already in the 1970‟s.101 Today, 
many national agencies and organizations around the world, including the Swedish National 
Food Agency, recommend at least two servings of fish per week, with an emphasis on fatty 
fish rich in omega-3.
102, 103
 These recommendations primarily relate to coronary heart disease 
(CHD) risk reduction. In addition to long-chain omega-3 fatty acids, fish contains several 
other nutrients that may be hard to obtain in sufficient amounts from other food sources. Fish 
may also serve as a good source of high quality protein, and as an alternative to excessive red 
meat consumption. It is however important to note that fish is the major dietary source of 
exposure to some environmental contaminants whose health effects remain to be fully 
elucidated.
104, 105
 Although not further addressed in this thesis, it should also be noted that 
issues of sustainability add to the complexity of the topic of fish consumption.
106
 
2.2.1 Nutritional value 
2.2.1.1 Long-chain omega-3 fatty acids 
Fatty fish is the major food source of long-chain omega-3 fatty acids, including 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Smaller amounts of the EPA 
metabolite docosapentaenoic acid (DPA) are also present in fish.
107
 These fatty acids have 
unique properties and distinct biological functions due to their structure with a long carbon 
chain and the first double bond at three carbon atoms from the methyl terminal.
108
 The 
shorter-chain omega-3 fatty acid alpha-linolenic acid (ALA), which is present in fatty plant 
foods such as seeds and nuts, can only to a limited extent be converted to EPA and DHA. 
Thus, direct dietary intake is the major determinant of circulating long-chain omega-3 fatty 
acid levels.
107
  
The long-chain omega-3 fatty acids exert their biological functions in various ways, including 
modulation of eicosanoid pathways, modulation of signaling pathways, incorporation into 
cell membranes, and effects on gene expression.
108
 They may influence cardiometabolic 
health by reducing plasma triglycerides, inflammation, heart rate, blood pressure, and platelet 
aggregation, preventing arrhythmias and improving endothelial function.
107
 
The effects of long-chain omega-3 fatty acid supplementation on major cardiovascular 
disease endpoints have however been less evident,
109
 suggesting that potential benefits of fish 
consumption indicated in observational studies may be attributed to a wider range of 
nutrients. The overall evidence from supplementation trials in specific populations of patients 
with impaired glucose metabolism do not support an effect on major cardiovascular events or 
mortality in this group.
110
 With regard to insulin sensitivity and glucose control, most trials 
have shown no effect.
110-112
 For type 2 diabetes incidence, no randomized controlled trials on 
the effect of long-chain omega-3 fatty acid supplementation have been carried out to date. 
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Circulating levels of long-chain omega-3 fatty acids were not associated with risk of type 2 
diabetes in the prospective studies included in a 2012 meta-analysis.
92
 Among subsequent 
studies examining circulating biomarkers, inverse associations were observed in some,
18, 113, 
114
 but not all.
115-117
  
2.2.1.2 Vitamin D 
Vitamin D is synthesized in the skin upon exposure to ultraviolet-B radiation. Other sources 
are however required to maintain adequate levels during winter at high latitudes. Few food 
sources contain significant amounts of vitamin D, and fatty fish is one of the most important 
contributors.
118
 Vitamin D has long been known to play an important role for bone health, 
with low levels associated with osteomalacia, lower bone mineral density, and higher risk of 
fractures. More recently, accumulating evidence has associated vitamin D with several other 
diseases.
119
  
Although inadequate vitamin D status has been observationally linked to higher type 2 
diabetes incidence,
120
 the causality of this association has been questioned.
121
 As summarized 
in a 2014 meta-analysis, most randomized controlled trials of vitamin D supplementation 
have not provided support for an effect on glucose homeostasis or diabetes prevention.
122
 
Observational evidence also associates low vitamin D status with higher risk of all-cause and 
cardiovascular mortality, as well as with incident CHD and stroke. Limited trial evidence on 
cardiovascular disease endpoints available to date is however inconclusive.
118
  
2.2.1.3 Selenium 
The selenium content of plant foods vary depending on the content of the soil. In areas with 
low soil content, such as in Sweden, fish is an important contributor to selenium intake.
123
 
Selenium is an essential trace nutrient and a component of several selenoproteins of 
importance for the body‟s antioxidative defense. Adequate selenium status may augment the 
defense system, but the beneficial dose range is relatively narrow. Supplement trials 
evaluating effects on glucose homeostasis and type 2 diabetes incidence have shown 
discrepant results that seem to depend on differences in baseline selenium status.
124
 For 
cardiovascular disease outcomes, a 2016 meta-analysis concluded that the overall 
observational evidence indicates an inverse association with selenium status, whereas 
randomized controlled trials do not support an effect of supplementation.
125
   
2.2.1.4 Protein 
Fish stands out among other animal foods by containing high amounts of high quality protein 
for low amounts of saturated fat. In addition, some of the specific amino acids found in high 
amounts in fish, such as arginine, glutamine, and taurine, have been shown to have beneficial 
effects on glucose tolerance, insulin sensitivity, and cardiovascular disease risk.
2, 126
  
 
2   Background 
 
 
14 
2.2.1.5 Other nutrients 
Fish is further a good source of other nutrients with potentially favorable effects on 
cardiometabolic health, including iodine,
127
 magnesium,
128-130
 potassium,
131, 132
 calcium,
130, 
133, 134
 and B vitamins.
135-137
 
2.2.2 Environmental contaminants 
2.2.2.1 Polychlorinated biphenyls 
Polychlorinated biphenyls (PCBs) are highly persistent fat-soluble compounds that were 
industrially produced during the 20
th
 century. Although production was banned in most parts 
of the world in the late 1970‟s, PCBs remain widespread in the environment.138 As they 
accumulate and magnify in the food chain, diet constitutes the major part of PCB exposure in 
the general population. Most of the dietary exposure originates from animal food sources, and 
the highest amounts are found in fish.
139, 140
 In Sweden, high levels have been observed in 
fatty fish from the Baltic Sea and contaminated lakes,
140
 and sensitive groups (children, 
adolescents, women of childbearing age, as well as pregnant and nursing women) are advised 
to limit their consumption of fatty fish from these waters.
103
  
Exposure to persistent organic pollutants such as PCB has been shown to induce insulin 
resistance in animal studies.
141
 In humans, circulating levels have been associated with higher 
risk of type 2 diabetes as well as cardiovascular diseases and associated risk factors.
142-144
 
Dietary PCB exposure has been associated with higher risk of MI and stroke in the cohorts 
studied in this thesis.
145-147
  
2.2.2.2 Methylmercury 
Mercury is a heavy metal, emitted into the atmosphere mainly from processes such as 
combustion of coal, waste incineration, smelting, and mining activities. To a smaller degree, 
it is also released from natural sources such as volcanic activity. Inorganic mercury is 
converted to organic methylmercury (MeHg) by microorganisms in lakes, rivers, and oceans. 
MeHg bioaccumulates in the food chain and can be found in high amounts in large predatory 
fish in some waters.
148
 High MeHg exposure, especially during fetal development, can 
damage the central nervous system. For this reason, the Swedish National Food Agency 
advices women who are pregnant, nursing, or planning a pregnancy to limit consumption of 
predatory fish species such as perch, pike, pikeperch, and tuna.
103
  
Due to its oxidative properties, MeHg has been proposed to have adverse effects on 
cardiometabolic health. In experimental studies, MeHg exposure has been shown to induce  
β-cell dysfunction,149 and to have a variety of effects related to cardiovascular risk.150 
Epidemiological findings on MeHg exposure are however inconsistent in relation to both type 
2 diabetes risk
18, 151, 152
 and cardiovascular disease outcomes.
153-156
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2.2.3 Prospective studies on fish consumption in relation to type 2 diabetes 
incidence 
The body of evidence from prospective cohort studies on the relationship between fish 
consumption and risk of type 2 diabetes has emerged over the past decade. The observed 
associations have ranged from inverse
14, 15
 to direct,
8, 10, 13
 with most studies reporting no 
statistically significant association with total fish consumption.
6, 7, 9, 11, 12, 16-19
 Results from our 
meta-analysis of these findings are presented in section 5.1. Various aspects of fish 
consumption that have not been assessed in many of these studies, such as type of fish, 
preparation methods, and degree of contamination, may be of importance in explaining the 
differences and understanding the potential role of fish consumption in type 2 diabetes 
development.  
2.2.4 Prospective studies on fish consumption in relation to cardiovascular 
disease and mortality among people with diabetes 
A relatively large body of observational evidence supports an inverse association between 
fish consumption and risk of major cardiovascular events such as CHD
3, 4
 and stroke,
5
 as well 
as overall mortality
157
 in the general population. Studies specifically in populations with 
prevalent diabetes are however more scarce.  
A strong inverse association with incident CHD events was observed among women with 
baseline type 2 diabetes in the Nurses‟ Health Study.20 In a smaller study of 117 cases, fish 
consumption was not associated with CHD risk.
21
 In a cohort of coronary artery disease 
patients, there was no clear associations between fish consumption and incidence of MI, 
either among those with or without prevalent diabetes.
22
 Dietary long-chain omega-3 fatty 
acid intake was however associated with lower risk of MI only among those with diabetes.
22
 
No studies have evaluated fish consumption in relation to stroke incidence among 
participants with prevalent diabetes.   
Three studies have assessed fish consumption in relation to total mortality in populations with 
diabetes. In the Nurses‟ Health Study, a strong inverse association was observed, similar to 
the one reported for incident CHD events.
20
 A modest statistically nonsignificant inverse 
association was observed in another US cohort.
158
 A smaller study including only 80 deaths 
reported no association.
159
   
  
3 AIMS 
The overall aim of this thesis was to evaluate fish consumption in relation to incident type 2 
diabetes as well as subsequent cardiovascular complications and mortality. 
 
The specific aims were:  
 to summarize results from published prospective studies on the associations of fish 
consumption and dietary intake of long-chain omega-3 fatty acids with risk of type 2 
diabetes (paper I)  
 
 to evaluate the validity of food frequency questionnaire (FFQ)-based estimates of 
long-chain omega-3 fatty acid intake and fish consumption (paper II) 
 
 to examine the associations of total fish consumption, fried fish, and specific fish 
items with risk of type 2 diabetes, taking exposure to environmental contaminants 
present in fish into consideration (paper III) 
 
 to assess consumption of total and specific types of fish in relation to risk of 
myocardial infarction (MI), stroke, and mortality among people with diagnosed type 2 
diabetes (paper IV) 
  
4 SUBJECTS AND METHODS 
Paper I in this thesis is a systematic review and meta-analysis of previously published 
evidence from prospective studies. Papers II – IV are based on data from two population-
based cohorts: the Swedish Mammography Cohort (SMC) and the Cohort of Swedish Men 
(COSM).  
4.1 META-ANALYSIS 
4.1.1 Search strategy 
The PubMed and EMBASE databases were searched for relevant articles published up to 15 
December 2011, using the search term “diabetes” combined with “fish”, “seafood”,  “long-
chain omega-3”, “long-chain n-3”, “docosahexaenoic acid”, “eicosapentaenoic acid”, or 
“fatty acids” and “cohort”, “prospective”, “follow-up”, or “longitudinal”. No language or 
other restrictions were imposed. Reference lists of retrieved articles were searched for 
additional relevant studies. For this thesis, an updated search was performed up to 29 
February 2016. 
4.1.2 Study selection 
The following inclusion criteria were applied: a) prospective study design; b) exposure of 
interest: fish consumption or dietary intake of long-chain omega-3 fatty acids; c) outcome of 
interest: incidence of type 2 diabetes; and d) relative risk (RR) estimates with 95% 
confidence intervals (CIs) reported. Odds ratios, risk ratios, and hazard ratios were considered 
estimates of the RR. If data from the same cohort were duplicated in more than one article, 
the one based on the largest number of cases was included.  
4.1.3 Data extraction 
From each study, we extracted the first author‟s last name, publication year, study country, 
study period, study size, sex and age of participants, categorization of exposure, methods for 
exposure assessment and  type 2 diabetes ascertainment, variables adjusted for in the analysis, 
and RR estimates with corresponding 95% CIs for each consumption category. If results from 
several multivariable models were reported, we extracted the risk estimates representing the 
highest degree of control for potential confounders. To obtain all necessary data, we 
contacted authors of studies that did not report information on the distribution of cases and 
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non-cases/person-time, or that presented RRs for only two exposure categories. Additional 
data were supplied by the authors of all five studies for which requests were made.
6, 9, 11, 15, 160
   
4.1.4 Quality assessment 
Study quality was assessed using the Newcastle-Ottawa Quality Assessment Scale for cohort 
studies.
161
 Each study was evaluated based on eight questions grouped into selection 
(representativeness of the exposed, selection of non-exposed, exposure ascertainment, 
exclusion of prevalent cases; 0–4 points), comparability (control for important covariates; 0–
2 points), and outcome (assessment of outcome, length of follow-up, completeness of follow-
up; 0–3 points).  
4.1.5 Statistical analysis 
We combined the results from published studies using a two-stage dose–response random 
effects meta-analysis. In the first stage, study-specific linear dose–response curves were 
estimated using a method that takes into account that the RRs for different exposure levels are 
not independent.
162
 For each category of exposure, the median or midpoint consumption was 
assigned as the dose for the corresponding RR estimate. Open ended consumption categories 
in the lower end were assumed to range from zero, and in the higher end to be of the same 
magnitude as the preceding category. To rescale fish consumption reported in grams into 
servings, we used 100 grams as an approximate average serving size. In the second stage of 
the meta-analysis, the study-specific trend estimates were combined.
163
 Potential departure 
from linearity in the relationship was assessed using restricted cubic splines with three knots 
at 10, 50, and 90% of the distribution. Statistical heterogeneity was evaluated with the 
Cochran Q-test and the I
2 
statistic, which quantifies the proportion of total variation that is 
explained by between-study variation.
164
 To explore sources of heterogeneity, we performed 
stratified analyses by sex, geographical region, methods for exposure and outcome 
assessment, and quality score. Sensitivity analyses included omission of one study at the time 
to evaluate if single studies markedly influenced the results, omission of studies with nested 
case-control design, and altering the fish serving size to 80 or 140 g for rescaling of exposure 
measures to servings. To assess publication bias, we used the Egger regression asymmetry 
test.
165
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4.2 COHORT STUDIES 
4.2.1 Study population 
Papers II – IV in this thesis are based on data from two population-based cohort studies, the 
SMC and the COSM, consisting of women and men from three counties in central Sweden 
(Figure 4.1). The studies have been approved by the Regional Ethical Review Board in 
Stockholm, Sweden, and all participants have given written informed consent. The cohorts 
have been shown to be representative of Swedish women and men of the same age, in terms  
of educational level, prevalence of overweight, and age distribution.
166
 Figure 4.2 provides 
an overview of the data collection and exclusions made to obtain the final study populations. 
 
 
Figure 4.1  Study area for the Swedish Mammography Cohort and the Cohort of Swedish Men 
4.2.1.1 The Swedish Mammography Cohort 
The SMC was established in 1987–1990. All women born between 1914 and 1948, resident 
in the counties of Uppsala and Västmanland, received an invitation to participate along with a 
self-administered questionnaire concerning diet and other lifestyle factors (response rate 
74%). In 1997, a second questionnaire was sent to all participants still alive and living in the 
study area (response rate 70%). The 1997 questionnaire version was expanded to include 
more food items as well as information on prevalent diabetes and important lifestyle factors 
such as cigarette smoking, physical activity, and dietary supplement use. In 2008, a new 
questionnaire on health, including a question on diabetes status, was distributed (response 
rate 63%). 
Between 2003 and 2009, cohort participants living in Uppsala were successively recruited to 
the SMC-clinical subcohort (SMC-C). Upon return of an additional food frequency 
questionnaire (FFQ), the women were invited to Samariterhemmet in Uppsala for a clinical 
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visit where fasting samples of blood, urine, and adipose tissue were collected. Weight and 
height were measured by a nurse, and measurements of bone mineral density and body 
composition were performed. Women who participated in phase 1 of the SMC-C (between 
2003 and 2004; n = 465) completed the same FFQ version as distributed to the whole cohort 
in 1997 and were eligible for inclusion in paper II. Adipose tissue samples were collected 
from 366 of these women (79%). Among these, 240 samples were randomly selected for 
analysis of fatty acid composition. One woman was excluded because she had returned a 
blank FFQ, resulting in a final study population of 239 women.  
In paper IV, we used data from the women who returned the 1997 FFQ. After exclusion of 
those who filled in an incorrect personal identity number, those who died, had a diagnosis of 
cancer (not including non-melanoma skin cancer), or cardiovascular disease (myocardial 
infarction [MI], angina, or stroke) before 1 January 1998, those with implausible total energy 
intake (±3 SD from the log-transformed mean), and those with missing FFQ data on all items 
in the fish consumption section or on frying frequency, 32,742 women remained. Among 
these, 912 women had a diagnosis of type 2 diabetes registered in the Swedish National 
Diabetes Register or the Swedish National Patient Register before 1 January 1998 and were 
included in the final study population.  
4.2.1.2 The Cohort of Swedish Men 
The COSM was established in the autumn of 1997, when all men born between 1918 and 
1952 and resident in the counties of Västmanland and Örebro were invited to participate. 
They received a self-administrated questionnaire, which with the exception of some sex-
specific questions was the same as the one distributed to SMC in 1997 (response rate 49%). 
An extended questionnaire on health, including a question on diabetes status, was sent out in 
2008 (response rate 78%).  
Among the men who returned the 1997 FFQ, 38,066 were left after exclusion of those who 
filled in an incorrect personal identity number, those who returned a blank questionnaire, 
those who died, had a diagnosis of cancer (not including non-melanoma skin cancer), or 
cardiovascular disease (MI, angina, or stroke) before 1 January 1998, those with implausible 
total energy intake (±3 SD from the log-transformed mean), and those with missing FFQ data 
on all items in the fish consumption section or on frying frequency.  
In paper III, men without any diabetes diagnosis before baseline (based on register data and 
self-reports) were considered. We further excluded those who reported a diabetes diagnosis in 
the 2008 questionnaire that was not confirmed by register data, and those who were registered 
with diabetes other than type 2 during follow-up, resulting in a final study population of 
35,583 men.  
In paper IV, the 1,313 COSM men with a diagnosis of type 2 diabetes registered in the 
Swedish National Diabetes Register or the Swedish National Patient Register before 1 
January 1998 were included, and pooled with the 912 SMC women.  
  
 
    
Figure 4.2  Data collection and exclusions for papers II – IV. CVD, cardiovascular disease; FFQ, food 
frequency questionnaire 
    
 
a 
registered diagnosis of type 2 diabetes in the Swedish National Diabetes Register or the Swedish National 
Patient Register before 1
 
January 1998 
b 
includes registered diagnoses of diabetes other than type 2 in the Swedish National Diabetes Register or the 
Swedish National Patient Register before 1
 
January 1998, and self-reported prevalent diabetes in the 1997 
questionnaire 
c 
self-reported prevalent diabetes in the 2008 questionnaire but no diagnosis record in the Swedish National 
Diabetes Register or the Swedish National Patient Register 
d
 registered diagnosis of diabetes other than type 2 in the Swedish National Diabetes Register or the Swedish 
National Patient Register between 1
 
January 1998 and 31 December 2012 
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4.2.2 Exposure and covariate assessment 
4.2.2.1 Questionnaire-based estimates of exposures and covariates 
The major part of the exposure data was collected via self-administered questionnaires, 
including extensive sections on diet, as well as questions on non-dietary lifestyle factors and 
health status. Dietary intake was assessed with semi-quantitative FFQs. This thesis is based 
mainly on the FFQ data from 1997 (FFQ-97), which is the baseline for the disease association 
studies (paper III and paper IV). In paper II, we additionally used data from two other FFQ 
assessments: the initial SMC recruitment in 1987–1990 (FFQ-87) and phase 1 of the SMC-C 
in 2003–2004 (FFQ-03).  
The FFQ-87 was a less extensive version including 67 food items. Participants were asked to 
report their average consumption of these foods over the past six months, choosing from 
eight predefined frequency categories ranging from never/seldom to four times per day or 
more. FFQ-97 and FFQ-03 were identical questionnaire versions, including 96 food items. 
Participants were queried about average consumption of these foods over the previous year, 
choosing from eight predefined frequency categories that ranged from less than one time per 
month to three times per day or more. 
For each food item, consumption expressed in servings per day was derived from the 
midpoint of the chosen frequency range. Consumption in grams per day was calculated based 
on age-specific portion sizes (≤52, 53–61, 62–69, ≥70 years for men; ≤52, 53–65, ≥66 years 
for women). The portion sizes were derived from weighted food records kept by random 
samples of 152 men and 213 women from the study area. For calculation of total energy and 
nutrient intakes, we used food composition values obtained from the Swedish National Food 
Agency database, which is based on analyses of representative foods on the Swedish market 
and takes into account cooking losses for prepared foods and dishes.
167
 For each FFQ item, 
nutrient calculations were based on an aggregate of a larger number of specific food types 
according to the distribution of consumption in the population. Nutrient intakes were further 
adjusted to the mean energy intake in the cohorts using the residual method.
168
 
Fish consumption 
FFQ-87 included two items on finfish consumption (salmon/mackerel/herring, other fish) and 
one item on shellfish (shrimp/mussels/crab). In FFQ-97/FFQ-03, three finfish items 
(herring/mackerel, salmon/whitefish/char, cod/saithe/fish fingers) and one item on shellfish 
(shrimp/crayfish) were included (Figure 4.3).  
In paper III and paper IV, non-response on fish items was assumed to imply never/seldom 
for participants who reported consumption of other items in the poultry/fish/egg section. Non-
responders of the entire section were left with missing values on fish consumption and 
excluded from the study populations. These assumptions were based on a study in a Swedish  
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population showing that 82% of missing reports on fish consumption corresponded to actual 
non-consumption.
169
 For the correlation analyses of fish consumption in paper II, all non-
response was treated as non-consumption.  
 
 
 
Figure 4.3  Food frequency questionnaire section on fish consumption (FFQ-97/FFQ-03) 
 
 
Total fish consumption was calculated as the sum of herring/mackerel, salmon/ 
whitefish/char, and cod/saithe/fish fingers. In paper II, as well as for the updated meta-
analysis presented in section 5.1.5, the sum of herring/mackerel and salmon/whitefish/char 
was used as an estimate of fatty fish consumption. In a separate FFQ section specifically on 
fried foods, participants were ask to report average monthly frequency of consuming fish 
fried in a pan (Figure 4.4).  
 
 
 
Figure 4.4  Food frequency questionnaire section on fried foods (FFQ-97/FFQ-03) 
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Validity of the FFQs has been evaluated in random samples of women and men from the 
study area. Among 248 men who completed fourteen repeated 24-h recall interviews during a 
one-year period, the correlations with FFQ-based estimates ranged from 0.44 to 0.81 for 
macronutrients and from 0.38 to 0.81 for micronutrients. For eicosapentaenoic acid (EPA) 
and docosahexaenoic acid (DHA), the correlation coefficients were 0.64 and 0.60, 
respectively.
170
 Food items have been validated among 129 women, with correlations 
between the FFQ-based estimates and those from four one-week weighted diet records of 0.5 
for fatty fish, 0.4 for lean fish, and 0.6 for shellfish (A. Wolk, unpublished data). Validity of 
FFQ-based estimates of fish consumption and dietary long-chain omega-3 fatty acid intake in 
comparison with adipose tissue content was assessed in paper II, and the results are 
presented in section 5.2.  
Other dietary factors 
To account for overall diet quality in the analyses of paper III and paper IV, we used a 
quality score instead of single food groups. We chose the DASH (Dietary Approaches to Stop 
Hypertension) diet component score proposed by Fung et al,
171
 as it has been associated with 
lower risk of type 2 diabetes and does not include fish consumption. The score was calculated 
based on reported consumption of eight dietary components. Higher points were awarded for 
high consumption of fruits, vegetables, nuts and legumes, low-fat dairy, and whole grain 
foods, and for low consumption of sodium, sweetened beverages, and red and processed 
meat.  
Dietary contaminant exposure 
For calculations of dietary exposure to polychlorinated biphenyls (PCBs) and methylmercury 
(MeHg), we used recipe-based databases previously created for the FFQ-97. Concentrations 
of PCBs and MeHg in foods were obtained from the Swedish National Food Agency and the 
Swedish Environmental Protection Agency's monitoring programs. The PCB database was 
based on concentration of congener 153 in over 1,200 food samples. PCB153 is the most 
abundant PCB congener in Swedish foods and an excellent indicator for total PCB. Time 
trends of PCB concentrations in food were taken into account to reflect concentration at 
baseline.
104
 The MeHg database was based on concentration data from 1,353 fish samples 
analyzed between 1975 and 2007, without any obvious time trend.
172
 Based on the FFQ 
responses, total dietary PCB and MeHg exposures were then calculated following the 
procedures for nutrient calculations described above (i.e. using age-specific portion sizes, 
aggregated codes, and energy-adjustment).  
The FFQ-based estimates of dietary PCB exposure have been validated in a subsample of 201 
SMC-C women. The correlation between the dietary exposure estimates and the sum of six 
PCB congeners measured in serum was 0.48.
104
 In another study of a Swedish population, a 
correlation of 0.75 was observed between FFQ-estimated fish consumption and hair 
mercury.
105
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Other health and lifestyle factors 
Information on other health and lifestyle factors, including body weight, height, education, 
alcohol consumption, smoking habits, physical activity, history of high cholesterol, history of 
hypertension, family history of MI, use of aspirin, and use of fish oil supplements was also 
self-reported in the 1997 questionnaire. 
Body mass index (BMI; kg/m
2
) was calculated from reported values on weight and height. 
Physical activity was assessed with questions on active time spent doing home/household 
work, walking/bicycling, and exercising; on inactive time spent watching TV/reading and 
sleeping; and on level of occupational physical activity. In paper III, we used a score of total 
physical activity calculated by multiplying the reported amounts of these activities by their 
typical energy expenditure requirements expressed in metabolic equivalents (METs).
173
 In 
paper IV, we instead used the walking/bicycling variable as a proxy for physical activity.  
4.2.2.2 Clinical data and biomarker analysis 
In paper II, we used data collected within the SMC-C. Subcutaneous adipose tissue samples 
of 5–25 mg  were taken from the buttock with a fine needle attached to a vacuum tube and 
then stored at −80 °C until analyzed.174 Total fat mass and total lean mass were measured 
using dual-energy X-ray absorptiometry (DXA; Lunar Prodigy, Lunar Corp., Madison, WI, 
USA). The precision error of the measurements was 1.5% for total fat mass and 1.0% for 
total lean mass. These measurements were used to calculate body fat percentage.  
The adipose tissue samples were analyzed for fatty acid composition in 2011. After extraction 
and transmethylation, the fatty acids were separated by gas–liquid chromatography on a 30 m 
glass capillary column coated with Thermo TR-FAME (Thermo Electron Corporation, 
Waltham, MA, USA), with helium as a carrier gas. An Agilent Technologies system (Santa 
Clara, CA, USA) with temperature programmed to 150–260 °C was used. Individual fatty 
acids were identified by comparing retention times with fatty acid methyl ester standard Nu 
Check Prep (Elysian, MN, USA). The amount of each fatty acid was expressed as weight 
percentage of the sum of all fatty acids.   
4   Subjects and methods 
 
 
28 
4.2.3 Ascertainment of disease  
Using the Swedish personal identity number, the cohorts were linked to several national 
registers to identify participants with prevalent disease for exclusion purposes, as well as 
incident cases of the outcomes of interest in paper III and paper IV.  
4.2.3.1 The National Diabetes Register 
The Swedish National Diabetes Register was initiated in 1996 as a tool for quality assurance 
in diabetes care. It contains clinical information from patient visits in specialized as well as 
primary care, reported by trained physicians and nurses. Reporting is not mandatory, but 
highly encouraged. In 2013, 100% of specialist clinics and 95% of primary health care 
centers participated.
175
  
Since initiation in 1996, the coverage has gradually improved.
24, 176
 Based on an expected 
diabetes prevalence of 4% of adults, the national coverage is now estimated to about 97% 
with some variation across the country. Västmanland and Örebro counties reach complete 
coverage based on this estimation, while about 62% are covered in Uppsala County. In 
comparison with the Swedish Prescribed Drug Register, it has been shown that about 90% of 
people aged 50–80 years on diabetes medication were covered (Västmanland: 95%; Örebro: 
92%; Uppsala: 77%).
24
 Of note, the Diabetes Register includes a retrospective recording of 
debut year, allowing us to backdate the diabetes diagnosis for cohort participants that were 
first registered in the later years. 
The Diabetes Register defines type of diabetes in two ways. According to the epidemiological 
classification, patients diagnosed before the age of 30 years and with insulin treatment only 
are classified as type 1. Patients diagnosed at the age of 40 years or older, as well as patients 
at any age treated only with diet and/or oral agents are classified as type 2. Diabetes type is 
also reported according to the clinical assessment as type 1, type 2, or secondary diabetes.  
4.2.3.2 The National Patient Register 
The Swedish National Patient Register at the National Board of Health and Welfare was 
initiated in 1964 to collect data on health care use through physician reports. Since 1987, it 
has been nationwide with mandatory reporting for all in-patient care. The study counties, 
Uppsala, Örebro, and Västmanland, have been fully covered since 1964, 1975, and 1985, 
respectively. Since 2001, the Patient Register also includes outpatient physician visits in both 
private and public health care. Primary care is however not covered. The coverage is nearly 
complete for in-patient care, with a good validity for most diagnoses.
177
 The coverage for 
outpatient care has gradually improved but is still somewhat lower, especially from private 
health care providers.
177, 178
 Primary and secondary diagnoses are reported using a Swedish 
adaption of the International Classification of Diseases (ICD).  
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Cause of Death Register 
The Cause of Death Register at the National Board of Health and Welfare contains 
information on dates and causes of death since 1961. Deaths of all Swedish citizens are 
recorded irrespective of whether they occurred in Sweden or abroad. It has been estimated 
that 93% of all deaths are reported within 10 days, and 100% within 30 days.
179
 Deaths are 
recorded with underlying and contributing causes using ICD codes.  
4.2.3.3 Definitions of prevalent and incident cases 
Diabetes 
Information from the National Diabetes Register was combined with information from the 
National Patient Register (primary and secondary diagnoses) to define prevalent and incident 
cases of diabetes. The register data was further complemented with self-reported information 
on prevalent diabetes from the 1997 and 2008 questionnaires. Figure 4.5 illustrates how the 
three sources of information overlap and complement each other before and after the baseline 
in paper III and paper IV (1 January 1998).  
The first date from either of the two registers was used as an approximation of date of 
diabetes diagnosis. In addition to the registered visit dates, we also considered the year of 
diabetes debut retrospectively reported in the Diabetes Register (date manually set to 1 July). 
Among the cohort participants registered in the Diabetes Register, information on debut year 
was available for 84%. Overall, 40% of the diagnosis dates were derived from the backdated 
Diabetes Register data, 19% from the first Diabetes Register record, and 41% from the first 
Patient Register record.  
The registered data on diabetes type was somewhat inconsistent. About 14% of the cohort 
participants with diabetes had information on type that differed either within or between the 
two registers. We assigned the type with priority given to the Diabetes Register‟s 
epidemiological classification, followed by the clinical classification. For participants not 
registered in the Diabetes Register, and for those whose diabetes type was too inconsistently 
reported between visits, information from the Patient Register was used (ICD-10 code E10 
for type 1, E11 for type 2, E12 for malnutrition-related diabetes mellitus, E13 for other 
specified diabetes mellitus, and E14 for unspecified diabetes mellitus).  
In paper III, prevalent cases of diabetes within the COSM were excluded from the study 
population. Exclusion was made for any type of diabetes with diagnosis date before 1 January 
1998 according to register data, as well as for self-reported prevalent diabetes on the 1997 
questionnaire. Among 962 participants with pre-baseline diabetes according to self-report 
only, 530 were later registered in at least one of the two registers. Incident cases during 
follow-up through December 2012 were identified using the definition of type 2 diabetes and 
date of diagnosis described above. Figure 4.6 illustrates how the two registers contributed to 
the case identification year by year during follow-up. In total, 49% of the incident cases were
  
 
 
 
 
Figure 4.5  Overlap between the sources of diabetes information. Percentages of the total number of cohort 
participants with diabetes according to any source, after non-diabetes-related exclusions. For incident cases, 
numbers are calculated after exclusion of prevalent cases identified from any source. SMC, Swedish 
Mammography Cohort; COSM, Cohort of Swedish Men
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recorded in both registers, 38% in the Diabetes Register only, and 13% in the Patient Register 
only. The date of diabetes diagnosis was derived from the backdated Diabetes Register data 
for 39%, from the first Diabetes Register record for 34%, and from the first Patient Register 
record for 27% of the incident cases.  
 
 
 
 
Figure 4.6  Sources of case identification during follow-up in paper III   
 
 
In paper IV, only prevalent cases of type 2 diabetes were included in the study population. 
This selection was based on the definition of diabetes type and date of diagnosis described 
above. Self-reported diabetes was not considered because no information on type of diabetes 
or diagnosis date was available from the questionnaires. Among the 2,225 included 
participants, 82% were identified in both registers, 10% in the Diabetes Register only, and 
8% in the Patient Register only. An additional number of 1,323 cohort participants had self-
reported prevalent diabetes on the 1997 questionnaire but no registered diabetes diagnosis at 
baseline and were thus not included. Among these, 38% were identified in at least one of the 
two registers at a later date.   
Cardiovascular disease 
In paper III and paper IV, participants with cardiovascular disease before baseline were 
excluded. Exclusions were made for primary or secondary diagnoses with ICD-10 codes I20–
I25 (ischemic heart diseases), 163 (cerebral infarction), I61 (intracerebral hemorrhage), I60 
(subarachnoid hemorrhage), or I64 (stroke, not specified as hemorrhage or infarction) 
recorded in the Patient Register before 1 January 1998.  
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In paper IV, incident cases of MI were identified using ICD-10 code I21 (acute myocardial 
infarction) listed as primary diagnosis in the Patient Register, or as underlying cause of death 
in the Cause of Death Register. For stroke identification, primary diagnosis in the Patient 
Register or  underlying cause of death in the Cause of Death Register with ICD-10 codes 163 
(cerebral infarction), I61 (intracerebral hemorrhage), I60 (subarachnoid hemorrhage), or I64 
(stroke, not specified as hemorrhage or infarction) were used.  
Mortality 
For the analysis of mortality endpoints in paper IV, deaths occurring during follow-up were 
ascertained through the Cause of Death Register. Coronary heart disease (CHD)-related 
deaths were defined as those listed with ICD-10 codes I20–I25 (ischemic heart diseases) as 
underlying cause.  
4.2.4 Statistical analysis 
4.2.4.1 Validation  
In paper II, Pearson product-moment correlations were used to measure the strength of the 
relationship between FFQ-based long-chain omega-3 fatty acid intake estimates and the 
concentration of these fatty acids in adipose tissue. We also evaluated how reported total and 
fatty fish consumption correlated with long-chain omega-3 fatty acids in adipose tissue by 
using Spearman‟s rank correlations. The fatty acid intake estimates were expressed as 
percentages of total fat intake for analogy with the adipose tissue content data. We used 
natural logarithmic transformations to improve normality. Correlations with individual and 
total long-chain omega-3 fatty acids were assessed. We further evaluated how earlier reports 
of dietary intake (FFQ-87 and FFQ-97) and long-term average intake (mean of estimates 
from two or three FFQ assessments) correlated with adipose tissue content. Finally, the 
influence of body fatness was evaluated by means of stratified correlation analysis and linear 
regression analysis with an interaction term between FFQ-based total long-chain omega-3 
fatty acid intake and body fat percentage.  
4.2.4.2 Survival analysis 
In paper III and paper IV, we used Cox proportional hazards regression models to estimate 
hazard ratios (HRs) with 95% CIs for the associations of interest. Age was used as the 
underlying time scale in all analyses, and participants contributed person-time from 1 January 
1998 until the date of the diagnoses of interest, death, or end of follow-up (31 December 
2012). We assessed the associations by categories of total fish consumption as well as the 
three individual finfish items, shellfish, and fried fish. Trends across categories were tested by 
assigning each participant the median value in their respective exposure category and 
modeling this as a continuous variable. The proportional hazards assumption was tested with 
the Schoenfeld residual test, with no violations indicated.  
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All multivariable analyses were conducted adjusting for BMI, physical activity, education, 
cigarette smoking, total energy intake, intake of alcohol, and the DASH diet component 
score. In paper IV, the models additionally included time since diabetes diagnosis, history of 
high cholesterol, and history of hypertension; further adjustment for family history of MI 
before the age of 60 years, aspirin use, or fish oil supplement use did not change the 
associations and these variables were thus not included. Individual fish and shellfish items 
were mutually adjusted in all analyses. Missing values for covariates were treated as separate 
categories in the models.  
In paper III, we presented results from an additional multivariable model with further 
adjustment for dietary exposure to PCBs and MeHg. To explore the potential impact of 
adjustment for collinear variables, we also examined the association between total fish 
consumption and type 2 diabetes risk across strata of dietary PCB and MeHg exposure 
(median splits). The dose–response relationship between fried fish consumption and type 2 
diabetes incidence was examined using restricted cubic splines with knots at 10, 50, and 90% 
of the distribution.  
As paper IV included both women and men, we assessed potential interaction by sex using 
the likelihood ratio test to compare models with and without a cross-product term. Sensitivity 
analyses excluding cases that were identified during the first two years of follow-up were 
conducted in both paper III and paper IV. In paper III we further evaluated the impact of 
excluding participants who reported any use of fish oil supplements. We also performed 
analyses of total fish consumption using an alternative reference category of non-consumers.
  
5 RESULTS 
5.1 META-ANALYSIS ON TYPE 2 DIABETES INCIDENCE 
5.1.1 Literature search 
The literature search up to 15 December 2011 identified 2,474 articles, among which 21 were 
obtained for full-text review. Among these, five articles were excluded because of non-
eligible exposure and/or outcome definition, and two were outdated by subsequent 
publications on the same study populations. A total of fourteen publications were thus 
included in the meta-analysis.
6-15, 160, 180-182
 
5.1.2 Study characteristics 
The fourteen included articles were published between 2001 and 2011, and reported results 
from sixteen separate cohort studies. Altogether, these involved 527,441 study participants 
and 24,082 cases of diabetes. Thirteen of the studies reported results on fish consumption and 
thirteen on intake of long-chain omega-3 fatty acids. Seven studies were conducted in the 
US,
7, 8, 12, 13, 181
 four in Europe,
6, 9, 10, 180, 182
 four in Asia,
11, 14, 15
 and one in Australia.
160
  
All studies used self-administered or interviewer-administered food frequency questionnaires 
(FFQs) to collect dietary data. The exposure information was updated during follow-up in six 
of the studies.
8, 12, 15
 All but three studies
6, 10, 12
 used self-reports to identify diabetes cases. In 
some of these studies the self-reported information was followed up with confirmation from 
other sources.
8, 9, 13, 160, 180, 182
 The most frequently included covariates in the multivariable 
analyses were age, sex, energy intake, smoking, body mass index (BMI), physical activity, 
and alcohol intake. Thirteen of the studies reached a quality score of at least six stars out of 
nine on the Newcastle-Ottawa Quality Assessment Scale.
6, 8-12, 14, 15, 180-182
  
5.1.3 Summary associations 
For both fish consumption and dietary intake of long-chain omega-3 fatty acids, the results 
across studies were mixed, ranging from inverse to direct associations. Because of a high 
degree of statistical heterogeneity (fish, I
2 
= 81.3%; p = 0.001; long-chain omega-3 fatty 
acids, I
2 
= 78.3%; p = 0.001), we did not combine results into overall summary risk estimates. 
While sex, self-administered or interviewer-administered FFQ, study quality, or method for 
case ascertainment did not appreciably explain heterogeneity (Table 2, paper I), there were  
substantial differences according to geographical region (USA, Europe, Asia/Australia).  
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The estimated relative risks (RR) for type 2 diabetes associated with each serving per week 
increment in total fish consumption are shown in Figure 5.1, for individual studies and 
combined by geographical region. The summary RRs were 1.05 (95% CI 1.02–1.09) for 
studies conducted in the US, 1.03 (95% CI 0.96–1.11) for studies conducted in Europe, and 
0.98 (95% CI 0.97–1.00) for Asian studies.  
 
 
Figure 5.1  Relative risks with 95% confidence intervals for type 2 diabetes, for each serving per week 
increment in total fish consumption 
 
 
For dietary intake of long-chain omega-3 fatty acids, each 0.30 gram per day increment was 
associated with RRs of 1.17 (95% CI 1.09–1.26), 0.98 (95% CI 0.70–1.37), and 0.90 (95% CI 
0.82–0.98) in US, European, and Asian/Australian studies respectively. No evidence of 
publication bias was detected using the Egger test (fish, p = 0.85; long-chain omega-3 fatty 
acids, p = 0.10). We found no evidence of departure from linearity (fish, pnonlinearity =  0.81; 
long-chain omega-3 fatty acids, pnonlinearity = 0.76). 
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5.1.4 Sensitivity analyses 
Both the summary RR estimates and the measures of statistical heterogeneity remained 
largely similar in all sensitivity analyses. After omission of one study at the time, the overall 
I
2
 ranged from 70.2% to 82.8% for fish consumption, and from 73.2% to 80.1% for long-
chain omega-3 fatty acid intake. A high degree of heterogeneity remained also after changing 
the fish serving size from 100 grams to 80 grams (I
2 
= 82.5%), or to 140 grams (I
2 
= 78.9%). 
All US studies reported fish consumption in servings and were thus unaffected. The summary 
RRs in European and Asian studies for each serving per week increment were 1.02 (95% CI 
0.97–1.09) and 0.99 (95% CI 0.98–1.00) using 80 grams, and 1.04 (95% CI 0.94–1.14) and 
0.98 (95% CI 0.96–1.00) using 140 grams. Omission of three nested case-control studies 
from the meta-analysis of long-chain omega-3 fatty acid intake also had little impact, with the 
overall heterogeneity remaining high (I
2 
= 79.7%).  
5.1.5 Updated meta-analyses 
In an updated literature search up to 29 February 2016, five new eligible studies on fish 
consumption published after paper I were identified (including paper III). All of these were 
conducted in European populations.
17-19
 
16, 183
 In an updated meta-analysis incorporating the 
new findings, the statistical heterogeneity in the overall summary estimate remained (I
2 
= 
76.7%; p = 0.001). The null association in European studies also remained, with a summary 
RR for type 2 diabetes of 1.01 (95% CI, 0.99–1.02) for each serving per week increment in 
total fish consumption (Figure 5.2).    
 
 
Figure 5.2  Updated meta-analysis of European studies published through February 2016, including five new 
studies published during 2012–2015. Relative risks with 95% confidence intervals for type 2 diabetes, for each 
serving per week increment in total fish consumption. 
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With the five new publications, the number of studies on different types of fish allowed for 
meta-analytic summary of fatty fish, lean fish, and shellfish consumption in relation to type 2 
diabetes risk. The results are presented both overall and separately for studies conducted in 
Asia and Europe. No US studies reported results by types of fish.  
There was no association with neither fatty (Figure 5.3) nor lean fish (Figure 5.4). No 
statistically significant heterogeneity was observed in the overall summary estimates, 
although results on lean fish were heterogeneous within Europe. 
 
 
Figure 5.3  Relative risks with 95% confidence intervals for type 2 diabetes, for each serving per week 
increment in fatty fish consumption. Updated meta-analysis including studies published through February 2016. 
 
 
Results on shellfish differed substantially between regions (I
2
 = 77.1%; p = 0.001), with an 
inverse association with type 2 diabetes risk in Asian studies, and a direct association in 
European studies (Figure 5.5). The total number of studies on shellfish is however still 
limited.  
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Figure 5.4  Relative risks with 95% confidence intervals for type 2 diabetes, for each serving per week 
increment in lean fish consumption. Updated meta-analysis including studies published through February 2016. 
 
 
 
Figure 5.5  Relative risks with 95% confidence intervals for type 2 diabetes, for each serving per week 
increment in shellfish consumption. Updated meta-analysis including studies published through February 2016. 
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5.2 VALIDITY OF QUESTIONNAIRE-BASED EXPOSURE ESTIMATES 
Comparing estimates from FFQs filled in by the 239 women included in paper II, the mean 
fish consumption was somewhat higher in 2003 than in 1997. This owed to an increase in 
reported fatty fish consumption from 1.2 (±1.3) servings per week to 1.6 (±1.9) servings per 
week, whereas lean fish consumption decreased marginally from 0.9 (±1.2) servings per 
week to 0.8 (±0.7) servings per week. In FFQ-03, fish and seafood items (including caviar) 
collectively contributed to 77% of total long-chain omega-3 fatty acid intake (Figure 5.6). 
 
 
 
Figure 5.6  Major sources of dietary long-chain omega-3 fatty acid intake according to FFQ-03  
  
Pearson correlation coefficients for FFQ-based estimates of total and individual long-chain 
omega-3 fatty acid intake in comparison with their concentrations in adipose tissue are 
presented in Table 5.1. Validity was assessed as correlations for the estimates from FFQ-03, 
as it queried diet in the time frame expected to be reflected in adipose tissue. Significant 
correlations, although lower in strength, were observed also for long-term intake estimates 
derived from past FFQs. Using the mean intake from two or three FFQ assessments generally 
enhanced the correlations (Table 2, paper II). 
 
Table 5.1  Correlations between relative dietary intake (% of total fat intake) from three food frequency 
questionnaire assessments over 15 years and adipose tissue content  in 239 women 
 
FFQs vs. adipose tissue 
(mean time before adipose tissue sampling) 
 
 
 
FFQ-03
 
(1.8 months) 
FFQ-97
 
(6.5 years) 
FFQ-87 
(14.9 years) 
 Total long-chain omega-3 fatty acids 0.41
 
0.29 0.31 
 EPA 0.32
 
0.21 0.21 
 DPA 0.29
 
0.22 0.21 
 DHA 0.48 0.33 0.34 
Data are presented as Pearson correlation coefficients based on loge-transformed values. DHA, docosahexaenoic 
acid; DPA, docosapentaenoic acid; EPA, eicosapentaenoic acid; FFQ, food frequency questionnaire 
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We further performed a stratified analysis for total long-chain omega-3 fatty acids by tertiles 
of body fat percentage (data available for 233 women). The correlation between dietary 
intake estimated by FFQ-03 and adipose tissue content was lower among participants in the 
highest body fat percentage tertile (Table 3, paper II). A statistically significant interaction 
between dietary intake and body fat percentage in predicting adipose tissue content was 
detected using linear regression (pinteraction = 0.003).  
Spearman correlation coefficients for the FFQ-03 estimates of total and fatty fish 
consumption in comparison with concentrations of long-chain omega-3 fatty acids in adipose 
tissue are presented in Table 5.2. Fish consumption was correlated with the individual fatty 
acids in adipose tissue according to the same pattern as observed on the nutrient level, i.e., 
highest correlation with docosahexaenoic acid (DHA) and lowest with docosapentaenoic acid 
(DPA).  
 
Table 5.2  Correlations between fish consumption estimates from FFQ-03 and adipose tissue content of total and 
individual long-chain omega-3 fatty acids in in 239 women 
 
 
 
FFQ-03
 
total fish 
FFQ-03
 
fatty fish 
Adipose tissue 
  
 Total long-chain omega-3 fatty acids 0.29 0.31 
 EPA 0.27 0.29 
 DPA 0.18 0.19 
 DHA 0.34 0.36 
Data are presented as Spearman correlation coefficients. Total fish is the sum of herring/mackerel, salmon/ 
whitefish/char, and cod/saithe fish fingers; fatty fish is the sum of herring/mackerel and salmon/whitefish/char. 
DHA, docosahexaenoic acid; DPA, docosapentaenoic acid; EPA, eicosapentaenoic acid; FFQ, food frequency 
questionnaire 
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5.3 FISH CONSUMPTION IN RELATION TO TYPE 2 DIABETES INCIDENCE 
Among the men followed from 1 January 1998 up to 31 December 2012, we identified 3,624 
incident cases of type 2 diabetes. Baseline characteristics of the study participants are 
presented in Table 1, paper III.  
We observed no association between total fish consumption in the primary multivariable 
model adjusting for BMI, physical activity, education, cigarette smoking, alcohol, and dietary 
factors. Compared with men who consumed less than one serving per week, the hazard ratio 
(HR) for those who consumed four servings per week or more was 1.00 (95% CI 0.85–1.18). 
Further adjustment for dietary exposure to polychlorinated biphenyls (PCBs) and 
methylmercury (MeHg) had a marked impact on the risk estimates although the association 
remained statistically nonsignificant (HR = 0.79, 95% CI 0.60–1.04; Figure 5.7). 
 
 
 
Figure 5.7  Association between fish consumption and risk of type 2 diabetes, in multivariable analyses before 
and after adjustment for dietary exposure to polychlorinated biphenyls and methylmercury  
 
 
Fried fish consumption was associated with higher risk of type 2 diabetes, without a marked 
impact of additional adjustment for dietary contaminant exposures (Table 3, paper III). In a 
restricted cubic spline model, we found no evidence of a nonlinear association (pnonlinearity = 
0.21). The dose–response relationship is shown in Figure 5.8. Each serving per week 
increment in fried fish consumption was associated with a HR of 1.07 (95% CI 1.02–1.11). 
None of the finfish items were individually associated with type 2 diabetes risk, whereas a 
higher risk was observed for shellfish consumption (≥1 serving per week vs. never/seldom; 
HR = 1.21, 95% CI 1.07–1.36). The associations for individual fish and shellfish items, 
before and after adjustment for dietary contaminant exposures, are shown in Figure 5.9.  
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Figure 5.8  Linear dose–response hazard ratio (solid line) with 95% confidence intervals (short dashed lines) and 
hazard ratio estimated with a restricted cubic spline model (long dashed line) for the association between fried 
fish consumption and risk of type 2 diabetes. The histogram represents the distribution of fried fish consumption. 
 
 
 
 
  
Figure 5.9  Associations between consumption of individual fish items and risk of type 2 diabetes, in 
multivariable analyses before and after adjustment for dietary exposure to polychlorinated biphenyls and 
methylmercury 
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To assess the potential impact of misclassification of prevalent cases as incident, we 
performed sensitivity analyses excluding type 2 diabetes cases identified during the first two 
years of follow-up (n = 305). We further evaluated the associations after exclusion of fish oil 
supplement users (n = 1,649; 178 cases). The results were not markedly influenced by these 
exclusions, neither before nor after adjustment for dietary exposure to PCBs and MeHg. In an 
additional sensitivity analysis using only non-consumers as the reference group in the 
analysis of total fish consumption (n = 911; 2.6%), similar results were also observed both in 
the primary model and in the contaminant-adjusted model. 
As the dietary contaminant exposure estimates were relatively highly correlated with total 
fish consumption (PCBs, r = 0.77; MeHg, r = 0.70), we further explored the potential impact 
of the adjustment for collinear variables. The association between total fish consumption and 
risk of type 2 diabetes was fairly similar across strata of dietary PCB and MeHg exposures, 
supporting that collinearity did not produce spurious results in multivariable-adjusted model 
including these contaminants.  
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5.4 FISH CONSUMPTION IN RELATION TO CARDIOVASCULAR DISEASE 
AND MORTALITY AMONG PEOPLE WITH TYPE 2 DIABETES 
Among the 2,225 women and men in the cohorts with a diabetes diagnosis before baseline (1 
January 1998), we identified 333 incident cases of myocardial infarction (MI) and 321 
incident cases of stroke during follow-up through 31 December 2012. During the same 
period, 771 deaths occurred, of which 154 were registered with coronary heart disease (CHD) 
as underlying cause. The baseline characteristics of the study participants are presented in 
Table 1, paper IV.   
All results are presented for women and men combined as no statistically significant 
interactions by sex were observed. The associations between total fish consumption and 
incident MI and stroke, as well as total and CHD-related mortality are shown in Figure 5.10.  
 
 
 
Figure 5.10  Associations between total fish consumption and risk of myocardial infarction (MI) and stroke, and 
total and coronary heart disease (CHD)-related mortality among women and men with prevalent type 2 diabetes 
 
 
Total fish consumption was inversely associated with MI, with lower risk observed already at 
modest fish consumption levels. Compared with those who consumed no more than three 
servings per month, the multivariable-adjusted HRs were 0.66 (95% CI 0.47–0.92), 0.67 
(95% CI 0.47–0.96), and 0.60 (95% CI 0.39–0.92) for those who consumed one to two, two 
to three, and more than three servings per week, respectively. No association was observed 
with stroke. For total mortality, a modest inverse association was indicated but not 
statistically significant. The inverse association with CHD-related mortality was significant 
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only at the level of one to two servings per week compared with lower consumption (HR = 
0.53, 95% CI 0.32–0.90).  
Among the individual fish items, herring/mackerel consumption was associated with lower 
risk of MI (≥1 serving per week vs. <1 serving per month, HR = 0.70, 95% CI 0.50–0.98), 
whereas there were no associations with salmon/whitefish/char or shellfish. Consumption of 
one to three servings per month of cod/saithe/fish fingers was also inversely associated with 
MI (HR = 0.64, 95% CI 0.46–0.90), whereas the association was not statistically significant 
at higher consumption levels (Table 2, paper IV). In relation to the mortality outcomes, 
inverse associations were observed only for one to three servings per month of cod/saithe/fish 
fingers (Table 3, paper IV).  
For MI as well as for the mortality outcomes, the associations with fried fish were largely in 
line with what we observed for total fish. Compared with those in the lowest tertile of fried 
fish consumption, the multivariable HRs for those in the highest tertile were 0.69 (95% CI 
0.51–0.93) for MI, 0.91 (95% CI, 0.75–1.10) for total mortality, and 0.74 (95% CI 0.47–1.15) 
for CHD-related mortality. For stroke, the association with fried fish differed more from what 
was observed for total fish, but was still not statistically significant (HR = 1.25, 95% CI 0.93–
1.67). 
Sensitivity analyses excluding incident cases or deaths identified during the first two years of 
follow-up (MI: 49 cases; stroke: 34 cases; total mortality: 29 cases; CHD-related mortality: 8 
cases), had no marked impact on the results.    
  
6 DISCUSSION 
6.1 METHODOLOGICAL CONSIDERATIONS 
Observational epidemiology is associated with limitations and potential sources of error that 
are important to consider. Issues of relevance for the papers included in this thesis and their 
potential influence on the results are discussed in the following section. 
6.1.1 Random error 
Random error is the variability in the data due to chance and relates to the precision of the 
estimation. The amount of random error in an estimate can be reduced, and thus precision 
enhanced, by increasing the sample size. In cohort studies, the limiting quantity is usually the 
number of cases.
184
 
In the studies included in this thesis, precision is indicated using 95% confidence intervals 
(CIs). A narrow interval implies high precision of the point estimate. Formally, if the interval 
does not include the null value (a hazard ratio of 1.00) the association is considered to be 
statistically significant. The lower the strength of the association, the higher the precision 
needs to be to be able to reject a null hypothesis of no association. The probability to 
correctly reject the null hypothesis is called the statistical power.
184
 Given that most diet–
disease associations are relatively modest in strength, and that variation is augmented by 
inevitable measurement errors in dietary assessments, studies of such associations require 
large sample sizes. 
In paper III, the large number of incident type 2 diabetes cases (n = 3,624) provided high 
statistical power. Although the data indicated an inverse association after adjustment for 
dietary contaminant exposures, the null hypothesis of no association could however not be 
formally rejected. Paper IV included a smaller number of cases for all outcomes. The results 
for myocardial infarction (MI) were however statistically significant despite relatively few 
cases (n = 333). The analyses of coronary heart disease (CHD)-related deaths (n = 154) 
would have benefited from higher statistical power.  
It is important to note that the formal interpretation of the CI applies under the assumption of 
no systematic errors, and thus relates only to chance as an alternative explanation for the 
findings. In view of the risk of non-chance related alternative explanations, evaluation of 
associations solely based on the arbitrary statistical significance dichotomy should be 
avoided. The strength and the precision of an association should always be considered in 
context of previous evidence, biological plausibility, and potential bias. 
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6.1.2 Systematic error 
Systematic error refers to the type of errors that would remain even if the study was infinitely 
large. Such errors undermine the internal validity of a study, as they can distort results by 
either underestimation or overestimation of associations. Violations of internal validity can be 
broadly grouped into three major types of bias: selection bias, information bias, and 
confounding bias.
184
  
6.1.2.1 Selection bias 
Selection bias arises when participation in the study is related to both exposure and outcome 
status, which results in an association between exposure and outcome that differ between 
those who participated in the study and those who were eligible but did not participate. Such 
bias can originate both from the procedures of recruitment into the study and from differential 
completeness of follow-up.
184
  
In prospective cohort studies selection bias related to recruitment is generally prevented, as 
selection into the study cannot be dependent on an outcome that has not yet occurred. Bias 
related to non-complete follow-up may on the other hand be an issue, if the degree of follow-
up is related to exposure status. In paper III and paper IV, we aimed to minimize loss to 
follow-up by linkage of the Swedish personal identity number to national registers. The high 
coverage of the Cause of Death Register as well as of in-patient care in the National Patient 
Register enabled virtually complete follow-up in paper IV. Follow-up for type 2 diabetes is 
more challenging as the Patient Register does not cover primary care. As illustrated in Figure 
4.4 and Figure 4.5, the National Diabetes Register was the most important source for case 
ascertainment in paper III, but the combined use of the two registers was necessary for more 
comprehensive identification. The Diabetes Register currently reaches nearly complete 
coverage in the study area, but coverage was markedly lower during the earlier years of 
follow-up. Identification of early cases was substantially enhanced by the retrospective 
recording of diabetes debut year, but we have inevitably missed some cases that died before 
the coverage of the register improved. This loss to follow-up would result in selection bias 
only if it was related to fish consumption.  
Differential loss to follow-up may have affected some of the studies included in paper I 
because of case ascertainment that depended on self-reports. It is possible that less health-
conscious participants are less interested in completing additional questionnaires, which 
could lead to different response rates among high and low consumers of fish.  
6.1.2.2 Information bias 
Information bias is introduced by errors in measurements of the variables of interest. 
Measurement error for discrete variables is often referred to as misclassification, and can be 
further divided into differential or nondifferential. Misclassification of exposure is differential 
if it differs depending on outcome status and nondifferential if it is independent of outcome 
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status. The same applies for misclassification of outcome in relation to exposure status. 
Differential misclassification can bias the results in either direction and thus produce spurious 
associations between exposure and outcome. Nondifferential misclassification of binary 
variables results in underestimation of the strength of the association. For variables with more 
than two levels, results may also be biased away from the null.
184
 
Misclassification of exposure 
Dietary assessment is inevitably subject to some degree of misclassification, both because of 
normal within-person variation and the difficulties in correctly recalling and reporting dietary 
habits.  
In paper II, we aimed to assess the measurement error in the exposure estimates used in 
paper III and paper IV. Reasonable validity in the food frequency questionnaire (FFQ)-
based estimates was indicated by correlation coefficients of 0.4 for total long-chain omega-3 
fatty acid intake and 0.3 for total and fatty fish consumption. Correlations with dietary intake 
reported as long as fifteen years prior to adipose tissue sampling further support that the FFQ-
estimates can reflect intake over longer periods of time. Although the use of an objective 
biomarker is a strength, it should be noted that the correlations reflect a relative validity as the 
adipose tissue content of long-chain omega-3 fatty acids is not a perfect reflection of actual 
dietary intake. In addition, biomarker measurements can also be subject to misclassification 
due to factors related to sampling, storage, laboratory measurement errors, as well as 
biological within-person variation.  
In the original prospective studies of fish consumption (paper III and paper IV) as well as 
those included in the meta-analysis (paper I), all participants were free of the studied 
diseases when exposure information was collected. This prospective design prevents 
differential misclassification as the correctness of self-reports should not be dependent on a 
future outcome. However, the uncertainty in the register-derived date of diabetes diagnosis 
may have resulted in misclassification of some prevalent cases as incident in paper III, 
which in turn could have contributed to some differential misclassification of exposure (as 
discussed below under misclassification of outcome). Nondifferential misclassification of 
exposure has inevitably affected paper III, paper IV, and the studies included in paper I to 
some degree, which would most likely have attenuated the associations. Bias away from the 
null can however not be excluded because of the polychotomous exposure.     
Misclassification of outcome 
Because of the slow onset and vague initial symptoms, we can expect that a number of cohort 
participants who developed type 2 diabetes during follow-up in paper III remained 
undiagnosed. The tendency of underdiagnosis is most likely independent of fish 
consumption, and thus represents a nondifferential misclassification of a binary outcome that 
would bias the associations towards the null. However, we cannot exclude the possibility of 
differences in diabetes detection if fish consumption is related to an overall health 
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consciousness. It is possible that more health-conscious participants are more active in 
seeking medical care and therefore get diagnosed earlier. The opposite scenario is on the 
other hand also possible, i.e. that less health-conscious participants are likely to have a poorer 
health in general, resulting in greater medical attention and higher likelihood to have their 
diabetes detected and diagnosed.  
The uncertainty in the register-derived date of diabetes diagnosis poses an additional potential 
problem as some prevalent cases may have been misclassified as incident in paper III. As 
dietary counseling is an integral part of diabetes management, the prevalent disease may have 
affected actual dietary habits and/or the correctness in reports of dietary habits. To limit such 
impact, we based the exclusion of prevalent cases on self-reports in addition to the register 
data. We further performed sensitivity analyses excluding cases that were identified during 
the first two years of follow-up. The virtually unaffected results indicate no substantial 
influence.  
For the outcomes studied in paper IV (MI, stroke, and mortality), the National Patient 
Register and the Cause of Death Register are expected to provide virtually complete coverage 
and highly accurate information. Underascertainment of diabetes would however have 
influenced inclusion in the study population. This would be unfortunate because of the 
impairment of statistical power, but is unlikely to have biased the results.  
6.1.2.3 Confounding 
Confounding refers to distortion of results due to a factor that covaries with the studied 
exposure in the study population, and that is also independently associated with the studied 
disease. The effect of such a factor can in part or in whole explain an observed association (or 
lack thereof). To be defined as a confounder, the factor should not be an intermediate in the 
causal pathway between exposure and outcome, as a part of its effect in such a case would 
represent an effect of the exposure.
184
    
In observational studies where exposures are not randomly distributed between groups, 
clustering of health related habits and lifestyle factors is likely to result in confounding if 
these factors are not appropriately controlled for in the design or in the statistical analysis. 
Fish consumption may be related to healthier behaviors in general, which has the potential to 
confound associations towards the inverse direction. To obtain valid risk estimates, 
identification of and adjustment for confounders is therefore a critical issue.  
In the prospective studies included in this thesis (paper III and paper IV as well as studies 
included in paper I), confounding was controlled by restrictions and by inclusion of 
covariates in the statistical models. The studies included in paper I controlled for potential 
confounding to varying degrees. Factors such as age, sex, energy intake, smoking, body mass 
index (BMI), physical activity, and alcohol were included in most studies, while control for 
other factors varied substantially. There were however no apparent differences in results 
depending on the included covariates. In paper III and paper IV, several potentially 
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confounding factors, including demographic, medical, lifestyle and dietary factors seen as 
established or potential risk factors for the studied outcomes were taken into consideration. 
Confounding by age was accounted for as the time scale of the analyses. To account for diet, 
we used overall dietary quality as assessed by the DASH (Dietary Approaches to Stop 
Hypertension) score. An alternative approach with adjustment for individual dietary factors 
resulted in similar associations in all analyses.  
In paper III, the second multivariable model included variables of dietary contaminant 
exposure. These factors cannot be considered to be confounders as their potential effect on 
the outcome would be a part of the effect of fish consumption. Inclusion of such factors in the 
model represents a theoretical “removal” of their effect to evaluate what effect of fish 
consumption would remain. A potential problem with this approach is collinearity, because of 
the relatively high correlations between the estimated contaminant exposures and fish 
consumption. Given that the CIs were not heavily inflated, this did not appear to be an issue 
of great concern. An approach to explore this further was to examine the association across 
strata of contaminant exposures, with fairly similar estimates supporting that collinearity did 
not produce spurious results. Paper III has an important strength in the large number of 
cases, allowing us to control for a large number of factors. In paper IV, we were not able to 
include the relatively highly correlated dietary contaminant exposure variables because of the 
considerably smaller study size.  
It should be noted that covariates included in multivariable analyses also are subject to 
measurement error, which may lead to inadequate adjustment as some „residual‟ confounding 
remains.
184
 Most of the included covariates in paper III and paper IV are subject to the 
limitations of self-reported data. Because of a larger within-food variation for contaminants 
as compared to intrinsic components in food, the precision of the dietary contaminant 
exposure estimates may be further limited. Additional factors that are unknown or 
unmeasured may also have influenced the observed associations. Unmeasured factors of 
potential interest include family history of diabetes, use of medications, elevated blood 
glucose in the prediabetes range (paper III), measures of glycemic control or presence of 
other diabetes complications (paper IV), as well as aspects of diet not captured by the FFQ.  
6.1.3 Generalizability 
Generalizability, also called external validity, concerns the inference of results to an external 
population. Pursuit of representativeness to obtain generalizable results is however not 
necessarily a priority in studies of exposure–disease associations. Restrictions of the study 
population can confer advantages with respect to confounding control, cooperativeness, 
accuracy of data collection, and optimal distribution of exposure. These advantages may be 
crucial to obtain an estimate of association that is valid within the studied population, which 
is a prerequisite for any external inference to be made. Restrictions will impair 
generalizability only if the characteristics that distinguish the studied population could 
reasonably modify the effect of the exposure.
184
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The Swedish Mammography Cohort (SMC) and the Cohort of Swedish Men (COSM) are 
population-based cohort studies, to which all women and men in a certain age range and 
residential area were invited to participate. The participation rate was 74% in the first SMC 
recruitment in 1987–1990 and 70% for the 1997 questionnaire. For the COSM, 49% of the 
invited men participated. Despite non-complete participation, the cohorts have been 
demonstrated to be representative of the Swedish population of middle-aged and older 
people, with regard to distribution of age, BMI, and educational level.
166
 Our results from 
paper III and paper IV can thus be considered to be directly generalizable to similar 
populations of middle-aged and older people in Sweden and other comparable countries. 
However, generalizability across geographical regions may be limited, as highlighted in 
paper I, because of differences in the characteristics of the fish consumption as well as 
potential genetic differences.    
For paper II, the potential impact of a non-representative sample is important to consider, as 
it is inherent in the aim of a validation study to be able to generalize the results from the 
subcohort to the entire cohort. Those willing to participate in the clinical subcohort may be 
more interested and motivated, and our results of validity may therefore be a slight 
overestimation of the questionnaire performance in the cohort as a whole. Moreover, paper 
II was based on women only, and generalizability to men may be somewhat limited. 
6.1.4 Meta-analysis 
Meta-analysis is a method for combining results from published studies on the same 
association. It can be a valuable tool to gain statistical power and to condense rapidly 
growing amounts of literature and accumulated evidence. It can also be a tool for contrasting 
results and identify patterns and sources of heterogeneity, as was the case in paper I.  
A meta-analysis naturally inherits the limitations of the included studies. Such limitations 
cannot be corrected and has to be considered when interpreting the summarized results. All 
studies included in paper I were of prospective design, and the strengths as well as potential 
limitations discussed above apply to them as well as to the original prospective cohort studies 
in this thesis. Additional sources of uncertainty are added by the combination of data from 
studies with different study protocols, and by necessary assumptions to allow combination.  
A further specific limitation of meta-analyses is the issue of publication bias. This stems from 
a tendency of papers being submitted, published, and cited depending on the strength and 
direction of association. Studies reporting “desirable” results may thus be more likely to be 
included in a meta-analysis, which would introduce bias. A common technique to assess 
publication bias is the funnel plot, in which the precision is plotted against the effect size for 
each included study. In the absence of publication bias, the plot should be symmetrical. The 
symmetry is evaluated statistically by the Egger regression asymmetry test. In paper I, no 
publication bias was indicated by this test.   
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6.2 MAIN FINDINGS AND INTERPRETATIONS 
6.2.1 Validity of questionnaire-based exposure estimates 
Results from paper II indicate reasonable capability of the FFQ to rank participants 
according to long-chain omega-3 fatty acid intake and fish consumption. The validity 
correlations for long-chain omega-3 fatty acids are in the upper range of most previously 
reported correlations with adipose tissue content.
185-195
 The strength of correlations however 
depends largely on the between-person variation in the population, which limits direct 
comparability between studies.
196
 The observed correlations with long-chain omega-3 fatty 
acid intake estimates derived from questionnaire assessments up to fifteen years prior to 
adipose tissue sampling support their usefulness in studies with long-term follow-up. 
By using an objective biomarker not based on self-reports we were able to evaluate the 
questionnaire performance against a measurement with independent sources of error. Adipose 
tissue provides the best biomarker reflection of intake of non-endogenously synthesized fatty 
acids over the preceding one to three years.
197, 198
 Although dietary intake is the primary 
determinant of long-chain omega-3 fatty acids in the body, it should be noted that the adipose 
tissue content is expressed as percentage of total fatty acids and thus includes endogenously 
synthesized fatty acids in the denominator. The lower correlation between FFQ-based 
estimates and adipose tissue content among participants with higher body fat percentage may 
be a result of a dilution by excess body fat. The adipose tissue concentration among leaner 
women might therefore be a better reflection of actual dietary intake, and the higher 
correlation in this group a better reflection of the FFQ validity. It is also possible that high-fat 
foods were selectively underreported among obese women,
199
 which may have led to an 
overestimation of relative long-chain omega-3 fatty acid intake in this group.  
6.2.2 Fish consumption in relation to type 2 diabetes incidence 
In paper I, we reported the first systematic review and meta-analysis of prospective studies 
on the risk of type 2 diabetes by fish consumption and dietary intake of long-chain omega-3 
fatty acids. Results from this large analysis including 24,082 cases among 527,441 study 
participants revealed substantial heterogeneity across geographical regions. The summary 
risk estimates indicated no association in European studies, a direct association in US studies, 
and an inverse association in Asian/Australian studies. Several additional meta-analyses were 
published around the same time and reached similar conclusions.
91-96
  
We noted that the number of studies conducted outside the US was limited. Since the 
publication of paper I, five new prospective cohort studies have been published, all based on 
European populations. Taking this new evidence into account in an updated meta-analysis, 
the paper I conclusion of no association in European studies still holds. No associations were 
observed in meta-analyses by types of finfish (fatty or lean). For shellfish, the results were 
6   Discussion 
 
 
54 
conflicting between regions with an inverse association in two Asian studies and a direct 
association in two European studies.    
Among the evidence adding to the updated meta-analysis was the study in the COSM (paper 
III). In this large cohort of Swedish men, the results were largely in line with previous 
evidence from European populations, with no overall association between total fish 
consumption and risk of type 2 diabetes. In a second multivariable model additionally 
adjusting for dietary exposure to environmental contaminants present in fish, there was a 
nonsignificant inverse association. It is possible that regional differences in exposure to 
contaminants via fish in part can explain the inconsistent results on the association between 
fish consumption and diabetes risk. Paper III is to our knowledge the first study to report 
results on this relationship taking dietary exposure to polychlorinated biphenyls (PCBs) and 
methylmercury (MeHg) into account. However, hair mercury measured in a Finnish study did 
not modify the association of fish consumption, nor of serum or dietary long-chain omega-3 
fatty acids, with risk of type 2 diabetes.
18
 The statistical “removal” of the influence of PCBs 
and MeHg in paper III is naturally only theoretical. For the population to fully benefit from 
the overall positive aspects of fish consumption, this needs to be replaced by active efforts to 
reduce environmental levels, paralleled by support for making sensible fish consumption 
choices. 
We further observed that fried fish consumption was associated with a higher risk of type 2 
diabetes. Different consumption and cooking habits between populations could thus be 
another possible explanation for the heterogeneity among studies of fish and diabetes risk. 
Among previous studies, one reported no association with fried fish consumption as opposed 
to an inverse association with total fish.
9
 Another study reported that adjustment for fried fish 
consumption attenuated a direct association with total fish.
10
 Possible explanations for 
differences in association by frying include increased energy-density, changes in fatty acid 
composition,
200
 or adverse effects by compounds formed during the frying process (such as 
advanced glycation end products and heterocyclic amines).
201, 202
 It is also possible that frying 
is a marker for other behaviors that influence the risk of type 2 diabetes.   
The inconsistent results for shellfish across regions warrant further investigation. Three 
additional studies presented results on shellfish consumption but did not report sufficient 
information to be included in the updated meta-analysis. The EPIC-Norfolk study supported a 
direct association in European populations with an odds ratio of 1.36 (95% CI 1.02–1.81) 
comparing at least one serving per week with less than one serving per week. Another 
European study reported a relative risk of 1.04 (95% CI 0.61–1.77) for consumers vs. non-
consumers. In the only US study on shellfish, consumption of shrimp, scallops, and lobster at 
least one time per month was associated with a relative risk of 1.06 (95% CI 0.97–1.13). In 
paper III, we observed a direct association that was not markedly influenced by adjustment 
for dietary PCB and MeHg exposure. Consumption habits could be of importance also for the 
observed results on shellfish. For example, in Sweden, and some other countries, shellfish is 
often consumed with mayonnaise or other fatty condiments.   
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6.2.3 Fish consumption in relation to cardiovascular disease and mortality 
among people with type 2 diabetes  
The findings from paper IV support that fish consumption is associated with a lower risk of 
MI but not with stroke among women and men with type 2 diabetes. The results for both total 
and CHD-related mortality were in the inverse direction but not statistically significant.  
As covered in the background section of this thesis, the proposed cardiovascular benefits of 
fish consumption have largely been attributed to the long-chain omega-3 fatty acid content, 
but may also be related to a wider range of nutrients. The overall observational evidence from 
studies in the general population supports an inverse association of fish consumption with 
cardiovascular disease and mortality.
3-5, 157
 As type 2 diabetes is characterized by metabolic 
abnormalities, dietary recommendations for this group can however not simply be based only 
on results from studies in populations without diabetes. 
Our findings are largely in line with the limited evidence from studies in populations with 
diabetes. Only three studies have assessed fish consumption in relation to incident CHD or 
MI, of which two included very small numbers of cases and observed no clear associations.
21, 
22
 In the substantially larger Nurses‟ Health Study, there was a strong inverse association 
which was suggested even at very modest total fish consumption of one to three servings per 
month.
20
 In our data, the lower risk of MI was also observed starting at the more moderate 
consumption levels. We could however not use a reference group with lower intake due to the 
limited number of participants reporting fish consumption of less than one serving per month.  
Fish consumption in relation to total mortality among people with diabetes has been 
addressed in three previous studies. In the Nurses‟ Health Study, a similar strong inverse 
association as for CHD incidence was observed.
20
 Another US study reported a modest 
nonsignificant inverse association,
158
 and a smaller Greek study including only 80 deaths 
reported no association.
159
 To our knowledge, there are no previous studies specifically on 
CHD-related mortality. Paper IV is also the first study to report on the risk of stroke by fish 
consumption in a population with diabetes at baseline. Our observation of no association 
among women and men with type 2 diabetes is in contrast to the overall evidence from 
observational studies in the general population, as summarized in a meta-analysis.
5
 The 
reason for this discrepancy is unknown and further studies are needed to confirm or refute our 
findings. 
For MI as well as for total and CHD-related mortality, we observed associations with fried 
fish consumption that were largely in line with the associations for total fish consumption. 
One of the previous studies of total mortality also assessed fried fish separately, and reported 
a similar nonsignificant inverse association as was observed for total fish consumption.
158
 
Our results on stroke were somewhat different for total and fried fish, which is more in line 
with some previous studies in the general population that have reported discrepancies in 
results for total and fried fish in relation to CHD, stroke, and other cardiovascular disease and 
mortality outcomes.
203-207
   
  
7 CONCLUSIONS 
Results from the papers included in this thesis showed that:  
 The accumulated observational evidence on fish consumption and dietary intake of 
long-chain omega-3 fatty acids in relation to type 2 diabetes risk is largely 
heterogeneous across geographical regions, with a higher risk observed in studies 
conducted in the US, no association in European studies, and an inverse association in 
Asian/Australian studies. 
 
 Food frequency questionnaire (FFQ)-based estimates of long-chain omega-3 fatty 
acid intake and fish consumption have reasonable validity and long-term stabilty, 
supporting their use in studies of diet–disease associations with long-term follow-up. 
 
 In a Swedish population of middle-aged and older men, there was no overall 
association between total fish consumption and type 2 diabetes incidence. Our  
results indicated that dietary exposure to environmental contaminants such as 
polychlorinated biphenyls (PCBs) and methylmercury (MeHg) may influence the 
relationship. Fried fish and shellfish consumption were associated with higher risk of 
type 2 diabetes.   
 
 Among Swedish middle-aged and older women and men with type 2 diabetes, fish 
consumption was associated with lower risk of myocardial infarction (MI), while 
there was no support for an association with stroke. The results for total and coronary 
heart disease (CHD)-related mortality were inconclusive with some suggestion of 
lower risk associated with moderate fish consumption.  
 
Overall, the results presented in this thesis do not challenge the current public health 
recommendations on regular fish consumption, neither for the general population nor for the 
high risk group of type 2 diabetes patients. General advice may however be too imprecise, 
and support for making sensible choices with regard to preparation methods as well as fish 
species varying in contamination may be needed in order for the population to fully benefit 
from increased consumption. 
 
  
8 FUTURE RESEARCH 
The results from this thesis contribute to the accumulating knowledge about the associations 
between fish consumption and risk of incident type 2 diabetes as well as some of its 
cardiovascular complications. Further research is needed to deepen the understanding and 
address remaining knowledge gaps, as proposed below.   
Food and nutrients are not consumed in isolation and thus need to be considered in the 
context of overall diet. Synergistic effects of dietary factors as well as interactions between 
diet and genes need to be addressed by future research. It would also be of interest to evaluate 
individual foods in comparison with their relevant alternatives using substitution analyses. 
For example, fish consumption should be evaluated as an alternative to other protein sources 
such as different types of meat. There is also a need to investigate more specific subtypes of 
foods, as well as preparation methods. With regard to exposure assessment, self-reported data 
on diet should ideally be complemented with objective biomarkers that reflect dietary intake. 
Repeated measurements are also desirable to account for changes in habits over time.  
More detailed dietary assessments are warranted to better capture exposure to contaminants 
via fish consumption. Self-reported data should ideally include a larger variety of fish species 
as well as their origin, and should preferably be complemented with measurements of 
objective biomarkers. More studies to directly assess the role of dietary contaminant 
exposures in relation to risk of type 2 diabetes as well as cardiovascular disease outcomes and 
mortality are needed. Elucidating their roles and at what doses they may be influential is 
necessary to understand how to optimize the health benefits of consuming fish. 
Most of the available evidence on dietary factors for diabetes prevention has been generated 
from studies in high-income countries. In view of the rapidly increasing burden of type 2 
diabetes and its complications in low- and middle-income countries, there is a need for more 
studies in other regions of the world where susceptibility as well as food consumption habits 
may differ.  
There is still very limited evidence from studies on dietary factors in relation to complications 
among people with diabetes, and thus gaps in the scientific basis for dietary recommendations 
in this group. This applies to the macrovascular complications studied in this thesis, but even 
more so for microvascular complications. Future studies are therefore warranted to evaluate 
the role of dietary factors in relation to complications of the eyes, kidneys, and nerves.  
The recent years‟ improvement in coverage of the Swedish National Diabetes Register is 
reassuring for future epidemiological studies in Sweden, and will contribute to improved 
identification of prevalent and incident diabetes cases. More comprehensive reporting of 
8   Future research 
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other variables will further enhance the possibilities of considering data on treatment, 
glycemic control, and other diabetes complications.  
Finally, beyond the important objective to improve understanding of the etiological role of 
diet, effective dietary management strategies for patients with type 2 diabetes require 
evaluation of adherence to recommendations. There is also a need to integrate knowledge of 
diet–disease relations with consideration of environmental implications of food choices to 
promote healthy habits that are sustainable in a broader perspective. 
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